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Interview Release Form 
 
Title of project:  Heroes of science – image, impacts and inspiration 
Name of researcher:  Elizabeth (Bobby) Cerini 
 
I (name of interviewee)       
of (address)  
give permission to the researcher to audio and/or video record an interview with me which will be/was held on  
(date of interview):    at (place of interview):  
1. I agree that the following conditions will apply to the use of the recordings and transcript and any other 
material arising from the above-mentioned interview:  
(a) The interview will be transcribed. 
(b) The transcripts and recordings can be edited. 
(c) Transcripts, recordings and other material may be indexed. 
2. I will be given the opportunity to review and correct where necessary any parts of the transcript selected for 
publication, prior to its finalisation. A copy of the recorded interview will be provided to me to facilitate this 
process.  
3. On completion of work on the interview, I will be given a final copy of the interview and a final copy of the 
transcript, if I so request.  
4. I assign all rights in the recording/s, transcript and other matter deriving from the interview to the researcher.  
5. The researcher may allow others access to the materials described in clause number 4 for bona fide 
research and education purposes.  
6. In any adaptation, broadcast, publication, public performance or any other forms of reproduction of whole or 
parts of the recording/s or transcript, my name may be acknowledged as the interviewee.  
7. I allow the researcher to use my interview, name, likeness and biographical material in connection with the 
publicity for the research project and for other purposes related to the project, in any medium including the 
Web and portable media devices.  
8. I release the researcher from any claim by me or anyone on my behalf arising out of the project and/or my 
appearance in publications arising from the project, and agree to indemnify the researcher in regard to such 
claim.  
9. I further understand that the researcher is under no obligation to include me in the published works arising 
from the project or obliged to complete or exploit the project in any manner.  
10. I understand that, prior to 1st October 2009, I can withdraw my personal information from use and/or 
request my data be destroyed, by contacting the researcher on bobby.cerini@anu.edu.au  
To signify your acceptance, please sign, date and return this Release Form to the researcher. 
 











































UK and Europe     7 July – 11 October 2008     
 
USA and Canada    14 October – 4 December 2008.    
 
Participating in the research. 
Interviews will be audio and/or video recorded and later transcribed. Participants are able to participate in a live or 
telephone interview or provide written answers to interview questions. Any participant may withdraw prior to 28
th
 February 
2009, by advising the researcher in writing. Information withdrawn by this date will be excluded from any further analysis or 
publication. 
 
Presentations about the research 
In 2008 the researcher will present papers at the Science and the Public conference in Manchester, England and at the Public 
Communication of Science and Technology (PCST) conference in Malmo, Sweden. Media promotions relating to the research 
and the public survey will be conducted throughout 2008 and 2009. 
 
For further information please contact: 
Researcher: 
 
Ms Bobby Cerini 
Email: Bobby.cerini@anu.edu.au 
URL: http://cpas.anu.edu.au/researchprojects/ 
URL: http://www.linkedin.com/pub/4/757/b4 
 
Telephone:  
USA/North American callers ‐ (202) 657 4036 
Australian callers ‐ (02) 6100 7743 
UK callers‐ 020 3239 2018 
 
Mobile: +1 314 359 3585 (USA) 
Fax: +61 2 8088 6161 
Supervisor: 
 
Dr Susan Stocklmayer 
Email: Sue.stocklmayer@anu.edu.au 
 
Telephone: +61 2 6125 8157 
 
Fax: +61 2 6125 8991 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Appendix	4:	Interview	protocol
	
Interview	questions	–	Heroes	in	Science	study.	
The	following	provides	an	overview	of	the	interview	questions	asked	in	the	course	of	this	study.	Each	
question	is	designed	as	a	starting	point	for	further	discussion	and	reflection.	This	list	highlights	the	
major	themes	of	the	study	and	questions	are	grouped	accordingly.	The	precise	question	order	is	
determined	at	time	of	interview,	based	on	the	flow	of	conversation	and	ideas	raised	by	the	interview	
candidate.		
Questions	are	often	expanded	at	interview,	for	example	by	asking:	‘You	mentioned....	Please	tell	me	
more	about	that.’		
The	questions	asked	will	vary	between	interviews,	according	to	the	time	available	and	context	of	the	
discussion.	Not	all	questions	will	be	asked	of	all	interview	candidates.	
	
Identity			 	
How	would	you	describe	your	personal	approach	to	communicating	(your	discipline).	
What’s	made	you	successful	in	(your	discipline)?	
	
Motivation	 	
Why	communicate	(your	discipline)?	
What	motivates	you	to	keep	going	(in	your	field)?	
What	particular	impacts	do	you	want	to	achieve?	
	 	 	
Inspiration/	Influences	 	
What	got	you	interested	in	doing	science	(or	related	discipline)?	
Were	there	any	particular	people	who	inspired	you?	
What	other	inspirational	experiences	did	you	have	(for	example	literature,	film,	fictional	characters,	
experiences	outside	school)?	
	
Relationships	 	
How	has	the	scientific	community	reacted	to	your	presence	in	the	public	eye?	
Have	you	noticed	any	change	over	time	in	how	communication	activities	are	viewed?	
How	would	you	describe	your	experiences	of	appearing	in	the	media?	
How	do	you	think	the	media	portrays	the	research	in	your	field?	
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How	would	you	describe	your	relationship	with	your	public	audience?	
What	kind	of	personal	contact	do	you	have	from	members	of	your	audiences?		
What	do	they	contact	you	about	and	what	do	you	think	motivates	them	to	contact	you?	
	
Values	 	 	
What’s	most	important	to	you,	in	doing	your	work?	
What	advice	do	you	have	for	people	following	in	your	footsteps?	
	
Character	 	
What	personal	qualities	have	made	you	a	successful	scientist?	
What	characteristics	have	made	you	a	successful	communicator?	
Where	did	you	acquire	these	qualities	and	characteristics?	
	 	 	
Benefits/Costs	 	
What	have	been	the	main	benefits	to	you	of	talking	about	your	work?	
Have	there	been	any	negative	repercussions,	or	negative	consequences?	
How	have	you	handled	the	pressures	of	being	in	the	media	spotlight?	
	
Training	 	
What	do	you	do	to	prepare	yourself	before	speaking	in	front	of	a	public	audience?	
What	training	or	coaching	have	you	had	in	dealing	with	the	media	or	talking	to	the	public?	
	
		323	
Appendix	5:	Interviewee	list	
	
NAME	 ACTIVITY	FIELD	 REFERENCE	SOURCE	
Johnny	Ball,		 maths,	science	presenter		
PERS.	COMM.;	NESTA;	C4;	
REFERRED	BY	INTERVIEWEE	
Elizabeth	Mills	 biology,	business,	OBE	 PERS.	COMM.	
Ron	Oxburgh	 environment,	business,	
policy	 REFERRED	BY	INTERVIEWEE	
Robert	May	 earth	science,	chief	scientist		 NESTA;	REFERRED	BY	INTERVIEWEE	
Raymond	
Tallis	 medicine,	philosopher	 REFERRED	BY	INTERVIEWEE	
Trevor	Baylis		
technology,	environment,	
inventor,	athlete	 WEB;	NESTA	
John	Sulston		 physician,	Nobel	laureate		 NOBEL	
Adam	Hart-
Davis	
broadcaster,	science	
communicator		 PERS.	COMM;	MEDIA	
Heinz	Wolff	
	physics,	science	
communicator		 MEDIA;	NESTA	
Jocelyn	Bell	
Burnell	 astronomy,	physics	 WEB;	ROYAL	SOC	LOCAL	HERO;	ASF	
Rory	Stear	
technology,	business,	
environment	 TIME	MAGAZINE;	WEB	
Kristine	
Pearson		
technology,	business,		
environment	 TIME	MAGAZINE;	WEB	
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Matt	Ridley,		
biology,	science	
communicator	 PERS.	COMM.;	MEDIA	
Robert	
Winston	 broadcaster,	academic	 NESTA;	WEB	
Hugh	
Montgomery	 physician,	author		 PERS.	COMM.	
Ian	Taylor	 minister,	policy	 PERS.	COMM.	
Kathy	Sykes	
broadcaster,	science	
communicator		 PERS.	COMM.	
Ian	Walker	
psychology,	human	
behaviour	 MEDIA;	PERS.	COMM.	
Quentin	
Cooper,	
broadcaster,	science	
communicator	 MEDIA;	PERS.	COMM.	
Jonathan	
Sanderson	 broadcaster,	producer	 MEDIA;	PERS.	COMM.	
Paul	Manners	 broadcaster,	producer		 MEDIA	
Sophie	Duncan	
broadcaster,	science	
communicator	 MEDIA	
Jonathan	Hare	
Physics,	science	
communicator	 MEDIA	
Aubrey	
Manning	 natural	history,	broadcaster	 PERS.	COMM.	
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Laura	Grant	
Physics,	science	
communicator	 PERS.	COMM.	
Sue	Black	 computer	science	 WEB	
Emily	
Cummins	 technology,environment	 PERS.	COMM.	
James	Burke	 broadcaster	 MY	HERO	SITE;	PERS.	COMM.	
David	
Attenborough		 natural	history,	broadcaster	
PERS.COMM.;	TIME	MAGAZINE;	
WEB	
Patrick	Moore	 	astronomy,	broadcaster	
PERS.	COMM.;	REFERRED	BY	
INTERVIEWEE;	WEB	
Chris	Lintott	
physics,	astronomy,	
broadcaster	 PERS.	COMM.	
Simon	Boxhall	 Oceanography	 PERS.	COMM.	
Tony	Juniper	
environment,	business,	
policy	 WEB	
Martin	Rees	 astronomy,	chief	scientist	 REFERRED	BY	INTERVIEWEE	
Simon	Gage	 producer	 PERS.	COMM.	
Ken	Calman	 medicine	 WEB;	PERS.	COMM.	
John	Coggins	 bioscience	 PERS.	COMM.	
Roland	Jackson	 science	educator	 PERS.	COMM.	
Simon	Singh	 science	journalist	 MEDIA;	PERS.	COMM.	
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Heather	
Couper	 astronomy	 MEDIA;	PERS.	COMM.	
Anne	Glover	
biochemistry,	business,	Chief	
Scientist	 PERS.	COMM.	
Michael	Atiyah	 maths	 FIELDS	MEDAL	
Julia	Higgins	 chemical	engineering	
REFERRED	BY	INTERVIEWEE;	
ROYAL	SOCIETY	
Nancy	
Rothwell	 materials	engineering	 REFERRED	BY	INTERVIEWEE;	WEB	
Tim	Hunkin	 inventor	 PERSONAL;	PERS.	COMM.	
Alec	Jeffries	 genetics,	forensic	science	 MEDIA;	WEB	
Harry	Kroto	 chemistry,	Nobel	Laureate	
NOBEL;	REFERRED	BY	
INTERVIEWEE	
George	Poste	 bioscience,	business	 MEDIA	
Neil	deGrasse	
Tyson	 astronomy	 MEDIA;	PERS.	COMM.;	WEB	
Steve	Rayner	 biology	 PERS.	COMM.	
Mark	Plotkin	 botany,	ethnography	 TIME	MAGAZINE;	PERS.	COMM.	
John	Mather	 astrophysics,	cosmology	 NOBEL	
Gil	Levin	 biology,	astrobiology	 REFERRED	BY	INTERVIEWEE	
Kathy	Sullivan	 geologist,	astronaut	 WEB;	PERS.	COMM.	
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Wally	Broecker	 climate	science	 WEB;	PERS.	COMM.	
Frank	Wilczek	 physics,	Nobel	laureate	 NOBEL	
Adam	Savage	 applied	science,	design	 MEDIA;	PERS.	COMM.	
Jamie	
Hyneman	 applied	science,	design	 MEDIA;	PERS.	COMM.	
Howard	
Bennett	 teacher,	environmentalist	 PERS.	COMM.	
Sylvia	Earle	 oceanography	
WEB;	TIME	MAGAZINE;	PERS.	
COMM.	
Courtney	
Schumacher	 engineering	 WEB	
Rudy	Marcus	 chemistry,	Nobel	laureate	 NOBEL	
Paul	Davies	 astronomy,	biology	 WEB;	PERS.	COMM.	
Lawrence	
Krauss	
physics,	
sciencecommunicator	 WEB	
Gerry	
Wasserburg	
cosmology,	earth	science,	
geology,	chemistry	 REFERRED	BY	INTERVIEWEE	
Larry	Edwards	 earth	science,	geology	 REFERRED	BY	INTERVIEWEE	
Averil	
McDonald	 science	communicator	 PERS.	COMM.	
Steve	Steiner	 nanotechnology	 PERS.	COMM.	
Bill	Fenical	 chemistry,	marine	science	 WEB	
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David	Suzuki	 genetics,	conservation	
PERSONAL;	PERS.	COMM.;	TIME	
MAGAZINE;	WEB	
Usha	Varanasi	 biology,	marine	science	 WEB	
Larry	Farwell	 neuroscience,	technology	 PERS.	COMM.	
Fraser	Mustard	 medicine,	epidemiology	 WEB;	PERS.	COMM.	
Bryan	Gaensler	 astronomy,	physics	
YOUNG	TALL	POPPY;	AUS	OF	YEAR	
YG;	
Frank	Fenner	 medicine,	immunology	 AUS	OF	YEAR;	BRIGHT	SPARCS	
Karl	
Kreuszelnicki	
broadcaster,	science	
communicator	 MEDIA;	PERS.	COMM.	
Anne	
Henderson-
Sellers,	 	climate	science	 NOBEL;	PERS.	COMM.	
Nancy	Millis	 bioscience	 WEB;	PERS.	COMM.	
Gus	Nossal	 medicine,	immunology	 PERS.	COMM.;	AUS	OF	YEAR	
Fiona	Stanley	 medicine,	epidemiology	 PERS.	COMM.;	AUS	OF	YEAR	
Ian	Fraser	 medicine	 AIPS;	AUS	OF	YEAR;	PERS.	COMM.	
Liz	Dennis	 botany,	genetics	 PM	PRIZE	
Jim	Peacock	
botany,	genetics,	Chief	
Scientist		 PERS.	COMM.;	PM	PRIZE	
Peter	Doherty	
medicine,	immunology,	
Nobel	laureate	 NOBEL;	AUS	OF	YEAR	
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Adam	Spencer	 maths,	broadcaster	 MEDIA;	PERS.	COMM.	
Robyn	
Williams	 broadcaster	 MEDIA;	PERS.	COMM.	
Helen	
Caldicott	
medicine,	conservation,	
advocacy	 MEDIA;	PERS.	COMM.	
Mike	Archer	 paleontology	 PERSONAL;	PERS.	COMM.	
Ian	Kiernan	 conservation,	business		 AUS	OF	YEAR	
Tim	Flannery	 climate	science	 AUS	OF	YEAR;	TIME	
Rob	Morrison	 science	communicator	 MEDIA;	PERS.	COMM.	
Ian	Lowe	
conservation,	science	
communicator	 PERS.	COMM.	
Barry	Marshall	 medicine,	Nobel	Laureate	 NOBEL	
Harry	Butler	 conservation,	business		 PERS.	COMM.;PERSONAL	
Robin	Warren	 pathology,	Nobel	Laureate	 NOBEL;	PERS.	COMM.	
Millie	Smith	 biology	 PERS.	COMM.	
Graeme	Clark	 medicine,	technology	 AUS	OF	YEAR	SNR;	PERS.	COMM.	
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Appendix	6:	Example	transcript		
Interviewer:	plain	text	
Interviewee:	italics	
Third	party;	assistant	to	interviewee:	bold	
	
	
I’m	Barry	Marshall,	clinical	professor	of	microbiology	at	the	University	of	Western	
Australia.	Nobel	prize	in	medicine	2005.	
Thanks	for	making	the	time	to	see	me.		
Thank	you.	
I	wanted	to	start	by	asking	you	about	your	personal	approach	to	communicating	
research	in	your	field.	You’ve	obviously	had	a	lot	of	experience	doing	so.	How	do	
you	personally	approach	it?	
Well,	I	was	a	bit	paranoid	about	it	initially,	cos	you	know	the	English	way	of	
dealing	with	publicity	and	medicine	is	not	to	have	any.	And	so	that	time	and	time	
again	you	hear	these	sad	stories	of	discoveries	and	things	being	done	in	England	
and	Australia	that	never	actually	get	commercialised	or	see	daylight.	And	as	a	
result	of	that,	people	don’t	know	about	it,	or	don’t	benefit	from	it.	So	I	learned	that	
lesson	early	on.	And	I	decided	that	I	needed	to	just	be	-	have	some	common	sense	
about	it.	Tread	carefully	initially,	but	I	never	really	had	any	commercial	gain	out	of	
publicity;	I	never	had	a	private	practice.	So	I	could	always	talk	about	medical	
research	pretty	easily.	And,	in	Western	Australia	once	I	started	trying	to	recruit	
patients	for	a	clinical	trial,	I	realised	the	way	to	do	it	was	through	the	media.	
Connect	up	the	right	way	with	the	media,	then	people	will	be	interested	in	helping	
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you,	and	having	new	discoveries,	testing	out	new	things.	And	pretty	soon	after	that	
I	went	and	I	set	myself	up	and	used	to	organise	my	own	publicity.	And	then	after	
that,	I	moved	to	the	United	States	in	1986,	and	was	very	quickly	upgraded	to	US-
style	media	(laughs).	And	understood	then	how	it	all	worked.	At	that	point	I	
realised	that	no	matter	how	many	thousands	of	patients	I	saw,	it	was	not	as	good	
as	being	on	ABC	News,	because	I	would	be	talking	to	thousands	of	doctors,	who	
would	see	hundreds	of	patients.	
Mm.	
Or	presenting	a	paper	and	getting	in	a	bit	of	a	to-and-fro	at	a	important,	national	
meeting	in	the	United	States	was	far	more	important	than	just	seeing	lots	of	
patients	and	answering	phone	calls	and	doing	the	things	I	could	do	in	my	own	
practice	or	in	my	own	hospital.	So	-	so	with	the	discovery	with	Dr	Warren	and	I	
where	-	you	know	-	feeling	our	way	with	the	idea	that	bacteria	cause	ulcers	-	once	
we	had	convinced	ourselves	and	tested	it	out	to	a	certain	extent,	then	all	we	had	to	
do	was	let	the	word	out.	Because	there	were	millions	of	people	out	there	looking	for	
a	cure	for	their	ulcer.	And	of	course	all	these	poor	people	were	labelled	as	being	
psycho,	neurotic	wrecks	with	ulcer	personalities	and	everything.	But	of	course	most	
of	them	were	just	normal	people,	so	you	can	imagine	how	frustrating	it	is	to	carry	a	
label	around	like	that.	And	just	-	just	because	you’ve	got	something	wrong	with	
you.	So,	well,	‘I	feel	like	a	normal	person	but	my	stomach	hurts	all	the	time	and	I	
feel	sick’,	you	know.	There	must	be	some	answer	to	this.	So	there	was	always	a	good	
audience	amongst	the	patients,	but	we	had	to	sort	of	get	through	this	barrier	of	
doctors	who	didn’t	want	to	put	the	word	out,	and	would	deny	it.	
Mm.	
So	I	then	realised	in	medical	research,	it’s	really	a	communication	job.	So	you’ll	do	
the	research.	At	that	point	you’ve	got	to	get	the	message	out.	Otherwise	it’s	wasted.	
Particularly	-	potentially	you	can	imagine	if	you’ve	discovered	a	cause	or	a	cure	for	
a	fatal	disease,	every	day	that	you	do	not	get	the	word	out,	somebody	dies.	And	
peptic	ulcer’s	like	that.	So	if	you	say	that	a	million	people	a	year	were	dying	from	
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bleeding	ulcers	-	I’m	just	guessing	at	a	number,	maybe	it’s	not	that	much	-	but,	so,	
you	divide	that	number	by	365,	and	every	day	where	you	just	keep	quiet	and	do	
nothing,	there’s	a	few	people	bite	the	dust,	just	because	they	didn’t	know	about	the	
new	discovery.	So	there’s	sort	of	a	moral	imperative	to	go	ahead	and	advertise	
important	new	discoveries.	It	would	be	immoral	just	to	do	nothing	about	it.	And	so,	
I	became	media	savvy.	And	I’d	be	-	because	of	my	hobby,	which	is	electronics,	
computing	and	all	that	stuff	-	I	had	my	own	Internet	site	when	most	people	hadn’t	
heard	of	the	Internet.	So	I	think	I	got	my	first	Internet	site	in	1984.	No,	1994.		
That	was	early,	yes.	
So	there	was,	there	was,	I	had,	I	remember,	if	only	I’d	kept	it,	I	had	my	first	email	
was,			barry@ibm.com	(laughs).	One	of	those	really	good	short	emails	that	I	didn’t	
pay	the	rent	on.	But	in	those	days,	you	could	get	your	name	on	important	domains.	
So,	I	went	around	and	rented	my	own	domains.	So	I	own	several	domains	called	
helicobacter.com,	hpylori.com,	breathtest.com,	anything	that	I	thought	would	be	
relevant,	I	went	and	signed	up	for	it.	And	so	then	when	I	-	at	that	point	I	was	doing	
a	lot	of	media	interviews	about	H.	pylori,	cos	it	started	to	catch	on	about	1994…	
Mm.	
Maybe	it’s	because	I	was	on	the	Internet.	It	really	accelerated	then,	and	maybe	I	
didn’t	realise	it	was	the	Internet.	But	whenever	I	did	an	interview	or	a	news	article,	
people	wanted	to	have	a	few	illustrations	and	some	photographs	and	resources,	an	
article,	stuff	like	that	-	just	normal	things.	And	it	was	always	-	oh	right,	I’m	gonna	
send	this	photo,	I	wonder	if	I’ll	ever	get	the	original	back,	you	know,	I’ve	got	to	
make	a	copy	-	so	I	was	always	forever	sending	off	the	same	stuff.	But	once	I	had	the	
Internet	I	realised	that	no	more	-	and	I	had	all	this	information	scanned	in	and	put	
in	all	different	places.	And	so	whenever	people	called	me	up,	I	would	give	them	the	
website	location	for	it	and	they’d	say,	‘http	-	what	is	that?’!	
Yes,	I	can	imagine.	
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So	very	quickly,	whenever	there	was	a	media	going	on,	they	would	be	able	to	get	-	
obtain	good	media	stuff	for	their	journal	or	whatever	it	was	from	me.	Up	to	the	
stage	that	by,	‘96,	people	were	saying	‘gee,	Barry,	who	does	your	publicity?’	Ha	ha!	
And	it	was	just	me.	Well,	I	had	a	few	smart	people	in	my	office	to	help	me	do	it.	But	
we	didn’t	really	have	a	publicity	campaign	running.	We	just	made	it	available	when	
people	needed	it.	And	so,	and	so	one	thing	led	to	another,	and	probably	my	biggest	
circulation	article	was	something	I	did	in	the	Reader’s	Digest	about	1988	or	89.	It	
was	pretty	corny	I	suppose.	It	was	called	‘The	Doctor	Who	Wouldn’t	Say	No’	or	
something	like	that.	But	apparently	they	reckon	that’s	been	read	by	360	million	
people.	Which	is	in	60	languages	from	Reader’s	Digest.	
So	a	tiny	readership!	
Oh	yes.	So	these	days	people	tend	to	know	about	H.	pylori.	Although	if	you	walk	
out	in	the	street	in	Australia,	half	the	people	would	still	tell	you	that	ulcers	were	
caused	by	stress.	
Mind	you,	most	people	seem	to	have	heard	of	the	stomach	ulcer	guys.	
Okay.	Yes	(dubious),	well,	who	were	you	talking	to,	though?		
People	often	ask	me…	
I	had	a	limo	driver	who	knew		
I’ve	had	taxi	drivers	who’ve	heard	about	it.	
Oh,	taxi	drivers!	But	they’ve	all	got	ulcers.	
And	they	know	everything!	
They	all	have	ulcers.	They’re	all	Lebanese	or	immigrants	with	H.	pylori,	so	that’s	a	
hot	spot	for	ulcers.	
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I	didn’t	realise	that.	
I	-	I	get	a	lot	from	taxi	drivers	and	had	a	taxi	driver	in	Edinburgh	who	gave	me	a	
bottle	of	single	malt	whisky	because	I’d	cured	him.	I	was	just	there	on	-	at	a	
conference,	and	he	somehow	was	asking	me	questions	and	found	out	that	I	was	the	
guy	who	discovered	that	ulcers	were	caused	by	bacteria.	And	he’d	had	the	
treatment.	
Well	I	have	to	say	I	recently	had	to	have	a	breath	test	and	I	would	have	-	if	it	had	
been	an	ulcer	I	would’ve	bought	you	a	bottle	of	whisky	as	well.		
Okay.	
You’re	so	miserable	when	you’ve	got	those	kind	of	symptoms	—	
Yes.	
Terrible.	
So	you	didn’t	have	it?	
I	had	my	gall	bladder	removed	instead.		
Oh!	
Yes.	
Much	better	to	take	antibiotics	if	you	can.	
That’s	what	I	think.	I	just	want	to	—	
Oh	you	had	a	laparoscopic	gall	bladder	out,	did	you?	
Yes.	
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Oh	wow.	That’s	pretty	good.	
Yes,	well.	It	wasn’t	my	finest	hour.	
I	can	tell	you	the	-	the	-	the	time	I	presented	this	first	in	the	United	States	was	this	
just	big	conference	and	they	had	about	three	thousand	people	plus	side	walls	with	
projectors	going	there.	And,	the	other	technology	that	was	announced	at	that	
conference	in	the	plenary	session	was	lithotripsy	for	gallstones.	You	know	-	
smashing	gallstones	from	outside	the	body?	And	that	just	went	by	the	wayside	
because	it	was	superseded	by	laparoscopic	cholecystectomy.	,	so	that	at	that	
plenary	session,	mine	was	the	weird	third	one	that	they	had	on	that	day.	I	can’t	
remember	what	the	second	one	was.	And	everyone	was	so	excited	about	lithotripsy	
because	it	was	so	expensive,	and	big	machines,	and	high	tech,	and	this	one	was	just	
antibiotics,	no	interest.	But	of	course	mine	proved	to	be	the	important	one	as	time	
went	by.		
Absolutely.	
Yes.	
It’s	amazing	hearing	you	talk	about	that	process	of	going	to	the	States,	and	that	
you	mentioned	that	you	quickly	gotten	embedded	into	the	US	style	of	media.	Can	
you	tell	me	a	bit	about	that?		
Well	my	connection	with	the	US	was	that	I’d	discovered	that	one	of	their	important	
over-the-counter	drugs	called	Pepto-Bismol	cured,	or	killed	Helicobacter,	at	least	in	
the	petri	dish.	So	the	-	the	vision	for	the	company	making	Pepto-Bismol,	Proctor	
and	Gamble,	was,	lo	and	behold	they	had	this	over-the-counter	medicine	that	was	
going	to	be	the	new	ulcer	treatment.	So	they	were	just	in	heaven	as	far	as	-	it’s	the	
best	thing	you	could	ever	discover.	So	they	funded	my	research	for	a	few	years.	I	
think	I	was	on	about	six	years	of	funding	with	three	or	four	salaries	on	it	at	the	
University	of	Virginia	till	91	or	92.	And	then	I	went	on	faculty	and	did	other	things.	
Um.	So	if	it’s	an	over-the-counter	medicine,	of	course	you	can	advertise	it	on	TV.	So	
these	are	marketing	people	who	were	funding	me.	Not	scientific	people.	As	much	as	
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-	there	were	both.	But	essentially	it	was	out	of	the	marketing	budget.	Cos	they	
already	had	the	product	on	the	market.	So	I	used	to	do	a	few	things.	And	then	I’d	
appear	on	the	morning	show	in	different	cities.	
Mm.	
From	time	to	time	when	I	was	at	a	conference.	And	I	became	a	little	bit	cynical.	And	
whenever	I	see	any	kind	of	health	publicity	now,	I	don’t	take	it	at	face	value.	I	say	
‘what’s	behind	that?’	And	I’ll	give	you	an	example.	If	you	show	me	a	story	about	
superbugs,	how	these	antibiotic	resistant	superbugs	are	creating	havoc	in	the	
hospital	and	somebody	could	die,	etcetera,	I	immediately	think	somebody	has	got	a	
new	antibiotic	for	superbugs	that’s	gonna	come	out	in	the	next	twelve	months	and	
they	want	us	to	be	worried	about	superbugs	so	they	can	sell	their	antibiotic	for	a	
thousand	dollars	a	day.	That’d	be	my	best	guess.	Where	does	superbug	publicity	
come	from?	Where	does	superbug	publicity	or	research	get	funded	from?	And	I’d	
say	the	makers	of	the	next	generation	antibiotic	against	superbugs.	And	I’m	
probably	right.	I	still	think	I’m	right.		
I	was	interested	by	you	talking	about	the	doctors	who	had	prevented	the	story	
getting	out,	as	it	were,	to	patients.	
Yes.		
What	was	behind	that,	do	you	think?	In	the	sense,	what	motivates	a	doctor	who	
hears	a	bit	about	some	research?	
Well	if	you’ve	got	a	new	technology	it	actually	requires	a	bit	of	effort	on	the	part	of	
the	physician.	He	has	to	learn	about	it.	So	there’s	downtime	for	him.	And	so	he	has	
to	understand	the	disease	and	know	the	risks	and	benefits	of	the	treatment,	and	
what	the	doses	are	with	the	different	antibiotics.	And	if	the	government	just,	if	the	
government	has	this	pack	already	made	up	which	says	-	and	you	just	write	for	
instance	for	example,	‘H.	pylori	treatment	Nexium	HP7,	take	as	directed’	-	easy.	But	
if	it’s	a	new	thing,	when	that	was	new,	and	it,	you	didn’t	have	it	all	in	a	triple	pack	
for	treatment	for	H.	pylori,	I’d	have	to	write	you	know,	what’s	the	dose	of	
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amoxicillin,	what’s	the	dose	of	neprozole,	what’s	the	dose	of	clarithromycin	[???],	
oh	my	goodness,	you	know.	So	you’d	have	all	these	prescriptions,	and	take	this,	and	
half	the	time	the	pharmacists	would	call	you	up	and	say,	oh,	if	you	give	it	this	way	
it	costs	twice	as	much,	and	—	
Mm.		
—	it’s	three	prescriptions.	So	the	alternative	is	the	patient’s	just	gonna	take	an	acid	
blocker	if	he’s	got	an	ulcer.	And	that’s	been	good	enough	for	the	past	ten	years.	
Why	should	I	change	unless	I’m	forced	to?	And	also,	you,	the	doctor’s	got	sweet	
spot	in	his	practice	where	he’s	most	efficient.	It	might	be	fifteen	minute	visits.	If	you	
go	to	the	next	longest	visit	you	do	twice	as	much	time	and	you	only	get	half	as	
much	reimbursement	or	something,	so	the	government	tweaks	the	system	to	have	
the	best	balance	of	number	of	patients	and	amount	of	funding.	So	it’s	a	government	
funding	issue	as	much	as	a	GP’s,	you	know,	money-grabbing	personality.	
Mm.	
So	he’s	there	and	he	says	well,	if	I	now	tell	this	-	want	to	treat	this	patient	for	H.	
pylori	I	have	to	do	a	blood	test.	I	have	to	explain	to	the	patient	for	twenty	minutes	
what	it’s	all	about.	And	I	have	to	get	the	patient	back	and	then	yes	and	no,	pros	and	
cons,	et	cetera.	It	becomes	a	big	effort	up	the	front	end	to	start	telling	people	about	
Helicobacter	pylori.	So	while	it	was	the	slightest	bit	experimental,	people	were	not	
really	going	to	do	it.	It	would	never	become	mainstream.	Although	if	you	wanted	to	
have	a	special	practice	where	you	specialised	in	really	tough	patients,	or	if	you’re	in	
a	public	hospital,	where,	you	know,	it	made	no	difference	whether	you	saw	one	
patient	or	ten,	you	didn’t	have	those	constraints.	So	you	could	sit	down	and	talk	to	
patients	and	tell	them	all	about	it.	And	then,	they	would	say,	oh,	if	you	want	this	
new	treatment,	you	have	to	go	to	the	hospital	and	see	the	registrar	or	somebody	
doing	research.	So	I	think	that’s	how	it	works.	So	that’s	how	it	worked	in	Australia.	
And	then	all	of	a	sudden	the	treatment	came	on	the	market	in	a	in	a	pack,	
promoted	by	a	drug	company.	So	that	the	drug	reps	then	went	around	to	all	the	
GPs	and	explained	it	to	them	so	they	were	all	experts	on	it.	And	there	was	
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information	in	the	media.	And	there	were	sample	packs.	And	there	was	a	PBS	
prescription	there’s	just	one	line,	whatever	it	might	be.	Then	everybody	can	get	it.	
So	as	soon	as	that	happened,	within	three	or	four	years	all	the	ulcer	patients	in	
Australia	were	treated.	So	it’s	just	a	few	stragglers	now.	You	can’t	find	ulcers.	And	
it	didn’t	happen	in	Australia	till	it	happened	in	America.	
Mm.	
Cos	that	is	where	the	information	flows	from.	And	that	is	where	the	drug	
companies	get	most	bang	for	their	buck,	when	they	put	out	a	new	treatment.	So	
although	it	was	kind	of	available	in	dribs	and	drabs	in	Australia,	it	was	still	hard	
work	to	do	it.	.	In	the	United	States,	the	companies	that	were	going	to	get	it	
approved	did	a	really	big	study,	and	it	took	them	a	year	or	two.	They	got	it	through	
the	FDA.	As	soon	as	it	was	approved	by	the	FDA,	this	marketing	campaign,	a	
hundred	million	dollars	of	marketing	just	went	out.	And	overnight,	it	was	almost	
malpractice	not	to	treat	it	with	antibiotics.	So	in	January,	you	didn’t	want	to	do	it,	
you	didn’t	have	to	do	it.	In	July,	all	of	a	sudden,	oh	my	god,	you	know,	I	have	to	
treat	it,	I	could	be	sued	or	something.	This	is	the	standard	of	care.	
Mm.	
So,	once	that	happened	in	the	United	States,	then	there	were	-	it	was	on	the	news,	
there	was	all	kinds	of	media	stuff	going	on	for	about	six	months,	and	then	it	was	a	
done	deal.	And	it	wasn’t	until	the	following	year	or	the	year	after	that	it	really	was	
funded	properly	in	Australia.	And	it	got	on	the	PBS.	
Yes.	
So	I	-	I’ve	got	a	lot	of	respect	for	marketing	and	communication.	And	but	somebody	
has	to	pay	for	it,	and	in	the	United	States	the	drug	companies	pay	for	it.	So	that’s	
part	of	their	drug	budget	if	you	like.	Maybe	50	million	dollar	launch.in	Australia	
obviously	you	can’t	spend	that	kind	of	money.	But	there	is	there	often	is	a	bit	of	a	
launch	out	to	the	GPs	et	cetera	when	a	new	product	comes	along.		
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Yes.	It’s	so	interesting.	
Yes.	
Because	I	think	it’s	one	of	those	aspects	of	how	technology	gets	adopted	in	
society	that’s	a	bit	invisible.	You	know,	to	think	about	the	marketing	and	the	
machine…	
Yes,	so	the	drug	companies	are	always	under	the	hammer,	regarding	their	free	
samples	and	their	junkets.	But	if	you	want	to	talk	to	a	hundred	GPs,	you’ve	got	to	
take	those	people	out	of	their	productive	job,	the	productive	part	of	their	job,	and	
grab	them	for	a	couple	of	hours,	and	convince	them	you’ve	got	a	new	treatment	of	
some	advance.	Otherwise	it’s	-	they	-	you	can’t	rely	on	them	doing	it.	It’s	like	taking	
someone	away	from	his	-	if	he	was	a	carpenter	-	and	say,	right,	next	week	I’m	going	
to	tell	you	about	new	kinds	of	pine	or	some	carpentry	thing,	and	all	these	guys	
earning	you	know	two	hundred	dollars	an	hour	at	some	job,	and	all	of	a	sudden	
they	earn	nothing	for	two	hours	and	learn	about	something.	It’s	hard	to	convince	
people	that	that’s	-	they’re	gonna	get	that	information,	that	value	back.	
Yes,	sure.	
So	in	the	States	it’s	obvious	that	private	industry,	pharmaceutical	companies	do	it.	
In	Australia,	it’s	harder	to	do	that	because	it’s	not	as	lucrative	for	them.		
Mm.	
So	I	don’t	think	you	can	necessarily	count	on	the	government	to	do	it	as	well.	
I	wondered	if	you	could	tell	me	a	bit	about	your	relationship	with	the	media,	and	
in	particular	how	or	whether	it	changed	as	a	result	of	winning	the	Nobel	Prize.	
Okay.	So	I	was	always	media	savvy.	And	it	was	always	easy	to	find	people	in	the	
media	who	had	ulcers.	And	they	would	find	me	as	much	as	I	would	find	them.	So	I	
used	to	wonder	why	journalists	got	so	many	ulcers.	But	once	I	decided	it	was	an	
		340	
infectious	disease	—	I’d	say	that	we	don’t	want	to	go	into	that	any	further!	But,	er,	
they’d	caught	it	off	their	partners,	or	they	travelled	to	Nicaragua	or	something	and	
picked	it	up	in	the	water	supply.	A	lot	of	reasons	why	journalists	would	have	more	
ulcers.	So	once	it	was	an	infectious	disease,	it	wasn’t	related	to	all	that	crazy	stress,	
deadlines.	It	was	just	that	they	picked	up	a	lot	more	germs	than	other	people,	
because	they	were	gregarious	meeting	people.	So	that’s	an	aside.	So	the	question	
was	how	did	I	use	the	media	in	the	US?	Is	that	what	you	were	saying?	
No,	it	was,	how	would	you	characterise	your	relationship	with	the	media,	and	did	
that	change	when	you	became	a	Nobel	Laureate?	
My	relationship	with	the	media	was	always	very	positive	and	I	was	always	
accessible	to	them	via	-	to	the	media.	I	always	made	myself	accessible	because	I	was	
receiving	a	lot	of	support	from	patients	and	doctors	long	before	it	was	official.	And	
that	is	because	I	knew	there	was	a	pent	up	demand,	which	was	tapped	by	the	media.	
So	I	owed	a	lot	of	favours	to	the	media,	I	can	say	that.	Numerous	anecdotes	related	
to	things	that	happened	that	were	useful	for	me	because	of	the	media.	And	so	about	
twenty	important	events	in	my	life	were	so	-	triggered	by	a	news	story	or	a	
journalist	called	me	and	told	me	something.	So	that	would	happen.	Now	once	the	-	
once	I	got	the	Nobel	Prize	it	became	a	bit	inundating	if	you	-	that’s	a	word.	
It	can	be	now.	I	think	it	would	be	a	word	for	most	Nobel	Laureates,	wouldn’t	
you?		
(Laughs.)	Yes.	So	you	cannot	-	it’s	impossible	to	manage	it	once	you	win	the	Nobel	
Prize	and	it	-	as	soon	as	the	announcement	goes,	you	could	then	spend	the	next	six	
months	on	the	phone	if	you	wanted	to.	
Mm-hm.	
So	Dr	Warren	and	I	spent	that	first	night	on	cell	phones	and	our	batteries	went	flat	
of	course.	So	there	we	were	borrowing	other	people’s	cell	phones,	and	we	had	the	
media	office	at	the	university	channelling	calls	through	to	another	cell	phone	which	
no	one	had	the	number	of.	So	that	straight	away	we	controlled	the	-	called	the	
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media	office.	Probably	because	I	was	media	savvy	I	knew	that	this	was	getting	out	
of	control.	So	at	that	point	we	had	the	hospital	and	the	university	media	office,	
organising	the	calls.	So	they	would	organise	us,	organise	it	on	one	phone,	and	then	
we’d	get	the	call	on	another	phone	so	that	it	was	manageable.	But	we	noticed	that	
drive	time	interviews	were	the	trap.	Because	you	realise	that	drive	time	travels	
around	the	world	with	the	time	zone.	So	there’s	always	drive	time	somewhere	in	the	
world.	So	if	you	start	saying	okay	I’ll	do	drive	time,	that’s	pretty	important.	Of	
course	you	do	Sydney	drive	time,	Melbourne,	Adelaide,	Perth,	Hong	Kong,	China,	
Thailand,	you	know.	It	-	and	you	end	up	you’re	doing	South	America	drive	time	six	
or	eight	hours	later.	Then	you’re	doing	morning	drive	time	somewhere	else,	in	
Sweden	[???],	so.	.	And	the	-	so	that	was	one	thing	I	learnt	-	you	can	do	you	-	there’s	
always	another	interview	you	can	do.	So	you’ve	just	gotta	draw	the	line	somewhere.	
The	second,	point	is	that	there	are	different	types	of	journalist.	Some	journalists	
will	do	their	homework.	And	others	are	just	talking	heads.	And	so	that	if	you	are	
just	one	of	these	talking	journalists,	then	you	might	be	just	told	to	do	an	interview	
with	Barry	Marshall	and	do	this,	ask	these	questions.	And	you	know	nothing	about	
it.	It’s	a	bit	hard	to	interact	with	people	like	that.	And	the	other	point	is	that	the	
editor’s	probably	already	written	the	story,	and	out	of	ten	questions	you	get	asked,	
only	one	of	them	is	important,	and	they	just	want	you	to	say	‘yes’	on	this	question.	
The	rest	of	it	is	thrown	in	the	bin	and	you	become	part	of	a	headline	on	a	tabloid	
newspaper.	So	that’s	happened	to	me.	And	so	I	occasionally	get	caught.	But,	as	a	
Nobel	Laureate	I	think	there’s	a	responsibility	to	be	credible.	And	so	that	after	the	
first	day	or	so,	Dr	Warren	and	I	had	a	meeting	with	Chris	Laurie	and	started	the	
office	of	Nobel	Laureates.	So	that	if	someone	wants	to	do	an	interview	a	-	with	us,	
the	question	would	be	‘is	it	relevant	to	what	we	do?’	There’s	no	point	asking	me	an	
engineering	question.	Actually	I’d	probably	know	the	answer	-	I’m	quite	interested	
in	engineering.	(Laughs.)	
But	if	it	was	something	a	bit	out	of	our	field,	it’d	be	better	that	we	didn’t	actually	do	
the	interview.	Otherwise	it’s	a	waste	of	our	time	and/or	a	waste	of	everyone	else’s.	
Um.	The	second	thing	is	that	we	can’t	do	every	single	interview,	and	we	would	try	to	
do	interviews,	get	information	out,	where	people	with	ulcers	for	example	or	people	
with	stomach	trouble	can	get,	obtain	some	useful	information	out	of	it,	and	
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perhaps,	point	them,	get	pointed	in	the	correct	direction	on	websites,	other	
resources.	And	then,	the	other	thing	we	could	talk	about	just	general	research	and	
health	questions.	So	we	have,	cos	we’re	the	Nobel	Laureates,	if	we	say	something	
‘gee	there	needs	to	be	more	funding	on	this,	it’s	obvious	that	the	government	should	
put	money	in’,	the	usual	kind	of	thing	that	academics	say,	maybe	because	we’re	the	
Nobel	Laureates,	if	someone	says	‘oh,	Barry	Marshall	or	Robin	Warren	said	this,	
it’s	more	likely	to	be	true	cos	they	don’t	just	say	anything’.	So	it’s	important	that	we	
don’t	just	say	anything.	So,	so	if	it’s	something	we’re	not	sure	about,	but	we	think	
it’s	important,	we	will	have	our	office,	and	spend	a	bit	of	time	ourselves	on	the	
internet,	make,	perhaps	make	a	few	background	phone	calls	ourselves,	and	make	
sure	that	we’re	not	just	giving	off	the	cuff	remarks,	but	if	we	make	a	remark	about	
something	that	we’re	not	a	full	bottle	on,	at	least	we	want	to	be	in	the	ballpark,	and	
have	some	knowledge	as	to	who	does	know	the	answers,	where	they	come	from.	
Mm.	You	say	that	as	though	you’ve	had	experience	of	not	necessarily	being	
caught	out,	but	maybe	the	phenomenon	that	seems	to	affect	other	Nobel	
Laureates.	And	Peter	[???]	described	this	at	a	conference	in	Sweden	last	year,	he	
said	the	temptation	to	speak	outside	your	area	of	expertise	is	immense	because	
journalists	assume	that	you	know	-	they’re	using	you	as	a	public	expert	and	so	
they	ask	you	about	all	sorts	of	stuff.	Have	you	had	experience	where	you’ve	felt	
that	you	went	too	far?	
Um	.	.	.	I’m	sure,	I’m	sure	there	is.	But,	generally,	perhaps	because	I’m	a	bit	careful,	
a	bit	savvy	—	
Mm.	
I	think	it’s	happened	to	me	over	the	years.	Long	before	the	Nobel	Prize.		
Mm.	
So	I		.	.	.	Robert	Macnamara,	he	said	it,	people	have	said	it	to	me	-	don’t	answer	the	
question	they	ask	you.	Answer	the	question	you	wished	they	asked	you.	Ha	ha!	So	
that’s	that’s	the	way	to	do	it.	And	the	other	the	other	thing	is	don’t	be	too,	you	
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know.	Everyone’s	gonna	make	mistakes.	But	you	don’t	want	to	waste	your	whole	
life	wringing	your	hands,	sack	cloth	and	ashes,	oh	no,	I	screwed	up.	Because	media	
is	very,	very	transient.	I	think	medical	research	-	you	know,	each	thing	you	do	is	like	
a	building	block	for	your	career.	So	you’re	going	to	end	up	there	and	it’s	based	on	all	
this	other	stuff	you	do.	.	I	suppose	there’s	a	bit	of	that	in	the	media,	but	in	fact,	even	
if	you	have	a	very	high	profile	story	about	some	research	on	the	news,	ten	per	cent	
of	the	population	saw	it,	ninety	per	cent	didn’t.	
Mm.	
So.	Of	course	the	ones	that	saw	you	screw	up	will	be	(laughs)	will	take	delight	in	
asking	you	about	it	(laughs).	So	that	-	that’ll	happen.	But	you	don’t	want	to	just,	
you	don’t	want	to	worry	about	it	too	much.	
Mm.	
Someone	else	-	in	Hollywood	they’d	say	there’s	no	such	thing	as	bad	publicity.	And	
that	is	almost	-	that’s	kind	of	true.	In	that,	if	you	have	some	bad	publicity	and	no	
one’s	ever	heard	of	you	before,	obviously	it’s	to	your	benefit	one	way	or	another.	
Because	you	might	be	the	focus	point	of	some	controversy	which	develops.	The	best	
example	is	today’s	papers.	Poor	public	servant	sent	a	fake	email	and	they’re	
interviewing	him	from	his	hospital	bed	in	a	psychiatric	hospital.	So	he	was	the	
fellow	Gretch.	
Godwin	Gretch,	yes.	
They’re	interviewing	him,	he’s	in	bed,	in	hospital	making	his	statement.	So	he’s	
probably	gone	too	far,	and	he’s,	he’s	now	worrying	about	it	a	bit	too	much.	
It’s	a	quite	a	massive	machine	really,	the	media.	As	you	pointed	out…	
It’s	actually	quite	hard	to	penetrate.	if	you	have	got	a	message,	and	you	don’t	know	
how	to	do	it,	it’s	very	hard	to	penetrate	the	media	or	a	lot	of	these	big	institutions,	
drug	companies,	for	example.	And	I	had	no	way	of	doing	it	when	I	was	starting	off	
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in	the	80s.	I	could	write	to	politicians	and	the	minister	for	health	and	drug	
companies,	and	nothing	I	did	went	anywhere.	And	then	I	suppose	I	had	some	media	
contacts,	so	that	I	bypassed	the	conventional	pathways	and	got	straight	to	the	
patients.	So	that	suited	me	at	the	time.	But	it’s	-	it	must	be	the	same,	it’s	very	
valuable	to	-	if	you’ve	got	something	to	sell,	or	something	that	you	want	done,	
media	time’s	very	very	valuable.	It’s	worth	anything.	So	it	has	to	be	filtered	I	
suppose.	
What	do	you	do	to	prepare	yourself	for	a	media	interview?	
Me?	Um.	I	try	to	be	fresh.	So	I’d	much	rather	have	an	early	night	than	sit	up	
worrying	about	it	too	much	and	trying	to	be	a	full	bottle	on	it.	I	think	media	
interviews	are	-	I	think	most	journalists	want	what	-	to	show	you	in	your	best	light,	
so	you	have	to	trust	them	that	they’ll	cut	out	all	the	bloopers	and	put	the	good	bits	
in.	So	usually	they’re	pretty	reliable	on	that.	,	The	second	thing	I’d	do	is	-	oh,	I’d	
usually	do	a	Google	search,	and	perhaps	just	look	at	a	few	online	researchers	and	
just,	so	that,	because	if	there’s	a	question	from	the	media	often	it’s	because	there’s	
something	that	triggered	it.	I’ll	say,	well	why	am	I	getting	this	question,	what’s	been	
going	on.	And	nine	times	out	of	ten	you	can	figure	out	what	exactly	is	happening.	
And	with	me,	because	I’m	a	Nobel	Laureate	now,	I	can	-	they’d	pick	up	the	phone	
and	I’d	call	whoever	it	is	that	is	creating	the	media	and	say,	what’s	going	on	here,	
you	know.	So	I	can	usually	find	out	exactly	what’s	happening.	And	so	I	often	give	a	
pretty	balanced	view.	And	so	quite	often	there’s	a	beat	up	story	about	for	instance	
beat	up	the	drug	companies	or	beat	up	somebody	or	somebody,	you	know,	
numerous	different	angles	to	it	[something???].	The	stem	cell	one	was	a	good	one.	
There	was	always	a	stem	cell	story.	And	I	kind	of	got	involved	with	that.	But	really	
I’m	not	a	stem	cell	expert.	So	I’d	have	to	just	know	-	more	know	a	person,	I	think.	
That	used	to	go	on.	So	I	do	that.	The	second	-	the	next	thing	would	be,	I’d	take	a	
powernap	if	it’s	in	the	afternoon	and	have	a	cup	of	coffee	before	I	did	it.	I	would	
assume	that	no	matter	how	bad	I	looked,	Australian	TV	crews	are	not	gonna	turn	
up	with	any	makeup	or	anything.	So	I’ve	seen	myself	look	like	I’ve	got	a	five	o’clock	
three	day	shadow,	and	I’m	on	the	cover	of	a	magazine,	so	(laughs),	I	think	a	little	
bit	about	that.	I	might	just	brush	and	give	myself	a	buzz	if	I’m	carrying	my	portable	
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shaver.	And,	if	it’s	a	hot	day,	I	might	grab	my	secretary’s	powder	and	take	the	shine	
off	my	head.	Course	there’s	less	hair	there	nowadays,	so	—	
(Laughs)	
—	I	can’t	trust	it.	And	I’m	prepared	to,	and	I	usually	talk	to	the	hospital	media	
person	or	the	university	media	person	so	that	I	can	arrange	parking	spots	for	
people,	it’s	not	too	rushed.	I	will	go,	give	a	heads	up	to	the	laboratory	people	in	my	
lab,	so	that	they	can	have	a	place	where	you	can	do	an	interview	if	they	want	to	do	
a	lab	interview.	And	usually	a	very	noisy	machine’s	around	in	labs,	so	that	they	
might	have	to	turn	the	machine	off	for	twenty	minutes,	and	that’s	a	bit	of	a	concern	
because	these	very	valuable	samples	are	in	these	machines,	so	there’s	many	issues	
like	that.	And		that’s	about	it.	I	try	to	give	short	answers.	
What’s	the	value	of	a	short	answer?	
If	you	can	give	a	one	sentence	answer,	then	it	-	the	whole	answer	will	be	on	the	TV	
as	you	said	it.	Whereas	if	you,	waffle	on	and	on	.	.	.	
Mm.	
And	I’ve	seen	too	many	scientists	want	to	qualify	it	twenty	different	ways.	And	at	
the	end	of	twenty	seconds	of	talking,	you	still	haven’t	got	the	answer	you	want.	At	
this	point	the	fellow	reading	the	news	pretty	much	cuts	in	and	says	well,	thanks	
very	much	Dr	Marshall,	off	we	go.	Everyone’s	saying	‘what	is	he	saying?’	The	other,	
the	other	trick	that	is	important	in	technique	is	to	repeat	the	question	before	the	
answer.	So	if	you	say,	‘what’s	the	latest	stuff	on	Helicobacter’,	I	wouldn’t	just	say,	
‘well	we’re	very	interested	in	the	DNA’.	You	gotta	say,	‘The	latest	thing	on	
Helicobacter	is	.	.	.’	That’s	wow,	this	is	great.		
I	can	tell	you	that	there’s	a	problem	I	think	in	Australian	media,	particularly	on	the	
radio,	talkback	shows.	The	ABC	DJs	-	they’re	DJs	I	s’pose	-	are	not	commercial-	if	
you	come	through	the	ABC,	you	don’t	have	this	commercial	feel.	You’re	not	
announcing	a	product	all	the	time.	And	quite	often,	you	come	in	about	one	minute	
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into	an	interview	which	goes	for	another	five	minutes,	and	you’re	saying,	‘what	is	
Norman	Swan	talking	about?	what	is	it?	what	are	we	talking	about	here?	this	
sounds	great!’	You	get	to	the	end	of	it,	you	say,	‘I	don’t	know!’	(Laughs)	
(Laughs)	
You	go	home	and	you	get	a	podcast	or	something,	and	you	try	to	figure	out	what	
was,	what	were	they	talking	about	in	the	first	minute.	And	so	that,	you	need	the,	
you	know,	every	sixty	seconds,	‘well	I’m	talking	with	Norman	Swan	about	the	latest	
treatment	for	arthritis.	A	new	drug’s	been	released.’	And	you	know,	you	need	to	say	
that	every	minute.	Otherwise	people	just	don’t	know	what	it’s	about.	
So	is	that	something	you	do	when	you	do	an	ABC	interview?	
Yes.	I	try	to	…	so	they	say,	‘well,	Barry,	tell	us	the	latest	thing	on	Helicobacter’.	I	
say,	‘well	you	remember	we	won	the	Nobel	Prize	for	discovering	the	germ	that	
causes	ulcers	and	it’s	called	Helicobacter.’	And	I’ll	keep	saying	it	every	now	and	
again.	Otherwise	people	get	in	there	and	they	say,	‘what	kind	of	a	virus	was	that?’	
You	know.	Means	nothing.	
That’s	a	really	good	point.	And	that	hasn’t	come	up	-	no	one	else	has	suggested	
that.	And	I	wondered	whether	you	could…	
So	annoying.	Well	now	that	I’ve	told	you	about	it,	you’ll	hear	it	time	and	time	again	
as	you	go	around.	You	get	in	the	car,	you	switch	it	on,	‘what	is	this?	what	am	I	
listening	to	here?’	
And	Norman	Swan’s	a	really	good	example	cos	his	stuff	is	so	interesting,	and	you	
do	hang	onto	it.	
I’m	probably	-	it’s	probably	unfair.	He	probably	knows	about	this.	
(Laughs.)	Sure.	
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I	think	he	does,	you	know,	reintroduce	it	several	times.	But	I	can	tell	you	that,	quite	
often	on	the	morning	shows	on	ABC,	or,	evening	shows,	there’ll	be	someone,	and	
they	haven’t	really	thought	about	it.	And	they	don’t	realise	there’s	thousands	and	
thousands	of	people	continually	switching	on	and	switching	off.	And,	you	know,	
how	long	are	you	going	to	listen	to	something	before	you	say,	I	give	up,	you	know,	
let’s	listen	to	music.	
Yes.	
It’s		just	right	underneath	your	thumb	now	on	the	steering	wheel,	you	just	click	
click	click	click	channel	surfing!	
And	you’re	quite	right.	Because	if	you	don’t	hear	it	within	thirty	seconds,	you’re	
just	gonna	move	to	something	you	do	get.	
And	who	is	this	person?	
Yes.	And	why	should	I	keep	listening	to	him?	
Mm.	
I	wondered	whether	you	could	just	talk	a	little	bit	about	the	differences	between	
US	media	and	the	Australian	media.	Do	you	see	that	there	are	any?	I	mean,	did	
you	notice	any?	
Oh,	I’d	say	obviously	my,	you	know,	ulcer	research	has	always	had	a	pretty	high	
profile.	So	it’s	relatively	easy	for	us	to	get	on	the	news	if	there’s	a	discovery.	And	
everything’s	resourced	much	better	on	the	big	networks	in	the	United	States.	
Though	they	really	do	have	a	newsroom	with	scientific	people	in	it.	People	with	
PhDs,	and	journalism	degrees	et	cetera.			whereas	I	think	it’s	it	gets	a	bit	thin	on	the	
ground	once	you	start	getting	out	to	the	local	networks.	They	might	have	one	
person.	And	a	news	reader.	And	then	so	in	Western	Australia	it’s	patchy	whether	
you	have	a	person	who	has	really	put	some	effort	into	a	news	story,	or	it’s	just	
copied	straight	off	the	fax	machine.	And	say,	right,	let’s	get	some	local	colour,	go	
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down	to	Dr	Marshall	and	ask	him	how	many	million	people	died	from	ulcers	this	
year.	Or	some	question	like	that.	And	you	know	that	-	well	I’m	okay	with	that.	I	
know	that	it’s	just	going	to	be	three	seconds,	and	there’ll	be	some	other	story,	and	
then	pop	a	bit	of	local	colour.	So	I	understand	that.	I	lot	of	people	don’t.	And	they	
will	think	that	they’re	going	to	do	a	ten-minute	interview	on	the	news.	And	I	know	
that	it’s	going	to	be	ten	seconds.	And	it	could	be	totally	-	it	could	be	left	off	or	might	
happen	next	year.	So	just	be	aware	of	that.	So	is	that	what	the	question	was?	The	
difference	between	media?		
Okay,	so	if	I,	if	there	is	a	news	story	about	ulcers,	Dr	Tim	or	somebody	from	ABC	
News	will	book	it	a	few	weeks	a	week	in	advance,	there’ll	be	a	sound	man,	a	camera	
man,	and	a	man	another	person	in	like	a	research	person	with	a	script,	and	then	
there’ll	be	a	celebrity	doctor	or	somebody	who’ll	sit	down,	and	he	has	researched	-	
no,	he’s	spent	a	few	hours	reading	it	on	the	plane	thinking	about	it.	So	it’s	a	proper	
news	story	that	you’ll	get	if	it’s	on	NBC	or	ABC	news.	And	so	you	should	be	
prepared	for	that.	It’ll	be	good	if	your	university	had	some	advance	warning,	if	
people	in	the	lab	knew	what	was	going	to	happen.	You	know,	you	were	set	up	for	it.	
If	it	was,	say,	Channel	7	or	Channel	9,	they	don’t	have	those	resources.	And	the	
person	who	interviews	you	has	to	do	five	other	stories	-	a	building	burning	down,	
something	at	the	courts,	you	know,	they’re	running	all	over	the	city.	So	they	can’t	
be	expected	to	know	all	about	H.	pylori.	And	so	then	it,	if	you	can	do	your	research,	
you	say	well	the	interesting	thing	is	this	-	why	don’t	you	ask	me	this	question	and	
that	question,	and	then	it	happens,	it	all	happens	in	ten	minutes	and	it’s	done	and	
it’s	successful.	So	it	often	helps	to	try	and	figure	out	what	the	questions	are	that	
people	will	be	interested	in	this	month.	And	then	you’re	at	a	big	advantage.	And	the	
journalist	goes	off,	it’s	effortless,	and	ends	up	with	a	tape	that’s	quite	interesting.	
I	get	the	impression	that	journalists	would	love	that.	
Yes.	It	makes	them	look	good.	
Like	they	did	all	the	work!	
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Yes!	
It’s	fascinating	talking	to	you.	I	think	that	you	and	other	Nobel	Laureates	I’ve	
spoken	to	have	got	this	experience	with	the	media	which	so	few	scientists	really	
tend	to	get.		
Mm.Probably,	just	from	the	amount	of	it,	the	other	thing	is	that	you	don’t	just	get	a	
Nobel	Prize	out	of	the	blue.	Although	you	don’t	know	-	there’s	plenty	of	good	
discoveries,	so	you	never	know	that	you’re	going	to	get	it,	you’re	gonna	win	it.	But	
the	Nobel	committee	likes	to	see	that	you’ve	been	mentioned	in	the	media	and	
you’ve	won	lots	of	other	prizes.	So	that	the	CV	of	a	Nobel	Laureate	consists	of	
several	other	international	prizes	in	different	countries.	So	Dr	Warren	and	I	have	
got	such	a	CV.	We	have	won,	if	there	was	in	quotes	“a	Nobel	Prize”	for	each	
country,	we	won	a	couple	of	US	Nobel	Prizes.	The	main	one	is	the	Lasker	Prize	in	
New	York	City.	We	won	the	German	Nobel	Prize.	We	won	a	few	prizes,	a	couple	of	
prizes	in	the	UK.	There	was	one,	a	medal	in	the	Royal	Society	that	I	won.	And	we	
won	the	Thai	Nobel	Prize,	which	is	called	the	Mahidol	Prize,	pronounced	Midol.	
And	we	won	a	couple	of	prizes	in	Australia.	So	the	Nobel	committee,	by	the	time	
you	win	the	Nobel	Prize,	you’ve	done	interviews	for	ten	years	—	
Mm.	
—	about	these	other	prizes.	And	the	best	example	of	the	prizes	is	the	Lasker	Prize.	
Now	I	think	there	is	actually	money	attached	to	it.	It	might	be	ten	thousand	
dollars.	The	Lasker	committee,	they	are	very	high	profile	scientists,	so	it’s	a	great	
committee	and	a	great	jury	if	you	like	for	their	prize.	So	no	effort	is	spared.	But	the	
ceremony	and	the	party	in	New	York	City	must	cost	them	a	couple	of	million	
dollars	I	think.	So	they	have	a	Lasker	Prize	office.	Maybe	three,	a	couple	of	publicity	
people,	and	medical	writers	in	it,	that	work	around	the	year,	running	this	thing	for	
the	Lasker	Prize.	And	then,	no	expense	is	spared	to	get	publicity	and	a	great	party	
for	everybody	in	New	York	City	for	the	Lasker	Prize.	So	it’s	the	most	fabulous	thing.	
And	once	you’ve	done	the	Lasker	well	you	say	oh,	I’m	kind	of	confident	that	I	could	
be	okay	at	a	Nobel	Prize.	Nothing	could	be	bigger	than	this.	But	it	is.	
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Yes.	
Um.	So	by	the	time	you	do	the	Nobel	Prize	you	do	actually	have	Nobel	Prize	
coaching.	A	lot	of	media	coaching	so	that	it	goes	smoothly.	But	usually	you’re	a	bit	
experienced	by	then.	
Yes,	that	makes	sense.	It’s	not	something	that’s	come	up	yet	either	—	
So	it’s	a	big	responsibility	with	the	Nobel	Prize.	It	has	to	be	an	important	discovery.	
And	it’s	important	that	everybody	agrees	that	it’s	a	good	one.	Otherwise…	cos	a	
couple	of	times	over	the	last	hundred	years,	the	Nobel	committee	has	made	a	
mistake.	And	awarded	a	Nobel	Prize	which	turned	out	to	be	wrong!	So	you	can	
imagine	this	big	responsibility	for	them	and	they	get	a	lot	of,	they	receive	comfort	
by	seeing	that	you	won	prizes	in	other	countries	that	were	a	big	success	as	well.	So	
it’s	fair	enough.	
Yes,	yes	it	is.	
So	I	know	that	now,	but	it’s	not	something	that	ordinary	people	would	be	aware	of.	
Mm.	I	want	to	move	to	asking	you	questions	about	your	early	career,	your	early	
life	actually.	
Yes.	
Why	medicine?	
Well	I	think	I	was	sort	of	attracted	to	it	anyway	because	my	mother	was	a	nurse.	
And	of	the	books,	you	know,	we	were	moving	around,	had	a	family	of	four	kids,	we	
didn’t	have	a	lot	of	money,	we	didn’t	weren’t	the	first	family	on	the	street	to	have	a	
TV	or	a	phone	or	anything,	or	a	car.		And	but	and	so	we	didn’t	have	a	lot	of	books	in	
our	house.	Although	I	was	a	keen	reader.	But	some	the	books	that	we	did	have	
would	be	the	-	my	mother’s	nursing	books.	So	she	probably	had	three	or	four	
textbooks.	And	they	would	have	interesting	pictures	of	babies	and	human	bodies	
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and	all	of	this	kind	of	stuff	that	you	imagine	are	pretty	normal	in	textbooks.	So	that	
was	interesting	stuff	to	read	about.	We’d	see	the	doctor	coming	to	give	us	
injections.	We’d	be	breaking	our	arm	and	going	getting	x-rays	down	at	Fremantle	
and	things	like	that.	So	we	had	plenty	of	interaction	with	medical	stuff.	The	other	
thing	I	had	were	my	dad’s	trade	books.	So	he	was	a	mechanical	fitter.	But	he	had	a,	
I	think	he	had	a	railway	steam	engine	ticket,	a	diesel	caterpillar	ticket,	and	he	
worked	on	marine	diesels	on	whaling	boats,	so	there	was	all	those	kind	of	technical	
books	as	he’d	done	his	trades.	So	I	knew	a	bit	about	electricity	and	mechanics	and	I	
even	knew,	he	then	did	refrigeration,	so	I	knew	even	about	weird	things	like	entropy	
when	I	was	about	twelve	years	old.	Entropy	was	some	interesting	concept	in	
thermodynamics.	And	people	kind	of	are	vaguely	aware	of	entropy	nowadays.	But	it	
was	something	that	hardly	any	kid	in	Australia	would	have	ever	heard	of	when	I	
was	a	kid.	.	So	I	was	going	to	be	in	science	or	engineering.	Also	of	course	interested	
in	dinosaurs	and	volcanoes	and	all	that	stuff.	Explosions	and	gunpowder.	
Chemistry.	So	I	always	loved	all	that	kind	of	thing.	And	I	was	a	bit	frightened	of	
mathematics.	This	story’s	in	the	Nobel	website	et	cetera.	But	the	first,	in	year	
eleven	at	school	I	had	the	flu	for	two	weeks	right	when	they	were	learning	linear	
algebra	or	something.	It	was	one	of	these	difficult	concepts.	And	I	never	really	
picked	up,	I	was	never	confident	on	that	area	of	mathematics.	And	I	had	the	feeling	
that	I	wasn’t	very	good	at	mathematics	after	that.	So	I	scraped	through.	I	don’t	
know,	I	got	65%	or	something.	And	I	liked,	I	was	good	at	calculus	and	different	
other	things.	But	I	felt	that	I	wasn’t	good	enough	at	mathematics	to	do	it	easily.	So	
that	steered	me	a	bit	away	from	engineering	and	electronics	and	I	did	medicine.	I	
found	that	medicine	was	also	requiring	some	mathematics	once	I	got	into	
statistics.	Anyway	so	I	still	had	a	bit	of	trouble	with	mathematics	there.	But	in	
retrospect,	I	think	it	was	that	illness,	cos	I	don’t	really	have	any	fear	about	
mathematics	anymore.	I	know	I	could	do	it	if	I	wanted	to.	
Mm.	
Anyway	so	that	got	me	into	medicine.	And	that	was	biology	and	chemistry.	
Mm.	
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And	I	found	that	I	was	also	very	good	at	medicine	be	-	well,	I	was	okay	at	medicine,	
let’s	say	-	because	I	had	a	lot	of	confidence	with	practical	procedures	and	
instrumentation,	gadgets.	So	you	could	put	me	into	any	new	ward	with	some	new	
ECG	machines	and	or	monitors	of	some	sort,	and	I’d	be	interested	in	reading	the	
manual,	figuring	out	how	it	works,	playing	with	the	dials,	getting	it	all	going.	And	if	
it	was	broken	I	could	get	it	started	up	again.	So	I	realised	how	important	that	stuff	
was.	With	a	lot	of	people	were	not	confident	with	machinery	of	any	kind.	And	I	was	
interested	in	it.	I	was	interested	in	actually	pulling	the	guts	out	of	it	and	seeing	
what	the	circuit	board	looked	like,	what	processor	was	on	it.	Cos	I	was	building	
computers.	So	it	was	a	fun	time	to	be	in	there	because	I	graduated	in	75.	So	between	
75	and	85	I	was	making,	doing	my	H.	pylori	stuff	and	research.	But	also	doing	
computers	and	electronics,	building	a	computer	and	making	my	own	word	
processor,	and	being	right	up	on	the	cutting	edge	with	all	that	technology,	which	
actually	helped	me.	Cos	I	could,	I	had	an	answering	machine	when	nobody	had	an	
answering	machine,	and	I	had	email	when	people	didn’t	even	know	what	it	was.	I	
could	communicate	with	people	in	South	America	in	1982.	I	was	doing	online	
literature	searches	before	people	realised	how	valuable	they	were,	how	much	time	
they	saved	you.	So	being	in	medicine	was	a	great	way	of	also	doing	electronics	and	
getting	value	out	of	it.	And	nowadays,	there’s	hardly	any	difference	between	the	two	
areas.	Information	technology	and	medicine	are	the	same,	particularly	genomics.	
So	that	it’s	like	it	turns	out	that	when	I	went	to	the	genome	centres	a	few	years	ago	
in	the	US,	I	found	out	that	the	software	they	developed	to	look	for	genes	in	great	
megabases,	megastrips	of	DNA,	was	actually	the	same	as	the	search	and	replace	
algorithm	in	Microsoft	Word.	So	the	guy	who	wrote	search	and	replace	on	
Microsoft	Word,	you	know	with	a	two	hundred	page	document,	go	straight	through	
-	it’s	exactly	the	same	as	looking	for	a	gene	in	a	big	line	of	DNA.	So	it’s	now	the	
same.	
I’m	not	sure	that	anyone	else	that	I’ve	spoken	to	would	agree	that	doing	
medicine’s	a	great	background	for	doing	electronics	or	vice	versa.	But	it	makes	
perfect	sense,	the	way	you	describe	it.	
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(Laughs)	Well	I	yes,	so	you’re	talking,	you’re	talking	about	the	media,	so	I	realised	
early	on	that	it’s	a	communication	business.	
Mm.	
And…I’ve	got	a	great	story	that,	it	well	-	you	know	I	was	saying	that	I	got	on	the	
internet	and	I	had	my	own	website,	people	could	email	me,	et	cetera.	,	We	did	an	
article	about	ulcer	bacteria	for	the	Parade	magazine,	which	is	the	lift	out	for	the	
Sunday	Times	in	the	United	States.	It	turns	out	that	they	circulate	this	to	40	
million	homes	in	the	US.	And	I	didn’t	-	they	franchise	it	out.	So	of	course	I	ended	up	
with	this	article	that	was	read	by	40	million	lay	people.	So	ten	per	cent	of	those	
people	would	have	been	taking	treatment	for	ulcers.	So	that’s	4	million	people.	Four	
million	ulcer	patients	read	about	me.	But	I	had	email	and	a	website.	We	put	our	
mailing	address	on	it.	A	week	later,	the	post	office	called	me	up	to	complain	that	
the	whole	place	was	-	we	had	one	little	post	box	of	course	and	they	had	six	rubbish	
bins	full	of	this	mail	that	was	coming	in.		
And	what	were	people	writing	to	you	about?	
Well	we	said	if	you	want	more	information,	send	a	stamped	addressed	envelope	to	
this.	So	people	couldn’t	be	bothered	buying	a	stamp,	so	they	would	just	put	two	
dollars	in	an	envelope.	So	we	probably	made	ten	thousand	dollars	just	by	extra	
money	that	we	had.	Ha	ha!	
Ha	ha!	
So	then,	then	we	got	the	volunteer	ladies	at	the	hospital	to	come	in	every	weekend	
and	just	stuff	envelopes	for	us.	And	in	the	envelope	we	said	if	you	want	to	find	-	if	
you	really	want	to	know	all	about	it	and	take	a	treatment	recommendation	package	
to	your	doctor,	send	us	ten	bucks	to	cover	shipping	and	handling…	A	month	later,	I	
had	forty	thousand	dollars	in	the	bank.	So	I	started	a	research	foundation	and	got	
tax	exempt	status	because	I	said	‘I	don’t	want	to	give	this	money	to	the	university,	I	
want	to	be	able	to	spend	it	on	my	research.	So	I	started	a	tax	exempt	foundation.	
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And	I	funded	a	research	fellow	for	about	a	year	and	a	half	just	on	stuff	that	came	in	
from	that	one	article	that	I	did.	
That’s	incredible…The	power	of	the	media.	
Yes.	That’s	how	it	happens.	
It’s	shocking,	in	a	way.	That	so	much	can	happen	out	of	one	article.	And	as	you	
said	you	had	this	experience	of	people	wanting	to	communicate	with	you	and	
they	did	.	.	.	
Yes,	a	lot	of	people	in	science	regard	it,	the	media,	as	a	hassle	and	an	
inconvenience.	But	if	you	treat	it	as	one	of	the	aspects	of	your	job	.	.	.	Well,	if	it’s	
dealing	with	patients	-	it’s	very	easy	for	me,	cos	I	could	always	see,	well,	somebody	
had	their	ulcer	treated,	and	they	would	have	had	surgery	tomorrow.	So	it’s	very	
easy	to	justify	it	on,	on	the	ulcer	basis…	So	a	lot	of	people	would	regard	it	as	a	
hassle	and	wouldn’t	do	it	properly,	and	it	would	become	a	hassle,	and	
inconvenience.	So	people	in	my	lab,	you	know,	obviously,	it	is	a	bit	of	an	
interruption	in	the	day’s	work	to	have	a	camera	crew	turn	up.	
Mm.	
And	you	learn.	Also	you	learn	that,	‘oh,	can	we	come	and	do	an	interview,	it’ll	just	
be	a	couple	of	questions,	and	it’ll	just	take	ten	minutes	or	so’.	It	never	happens.	
There’s	always	like	twenty	minutes	set	up	time,	or	half	an	hour’s	set	up	time,	and	
then,	you	know,	you	can’t	work	in	the	lab	for	an	hour	probably	while	they	set	up	the	
lighting.	Otherwise	you	end	up	with	an	interview	that’s	terrible.	So	you	-	it’s	a	waste	
of	time	doing	it	if	you	don’t	do	it	properly.		
It	was	interesting	hearing	you	talk	about	the	books.	My	mum	was	a	nurse,	so	
while	I	remember	her	textbooks	so	clearly,	I	was	fascinated	by	the	pictures	of	all	
the	diseases.	
Mm.	Mm.	
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That	to	me	was	quite	fascinating.			I	wonder	whether	you	had,	when	you	were	
younger,	particular	heroes	in	science	or	technology.	Or	people	you	looked	up	to…	
Well,	I	used	to	read	when	I	was	about	ten	or	eleven	or	twelve	I	started	reading	
novels.	And	so	I	used	to	like	these	biographical	novels.	So	they	must	have	had	them	
at	school.	They	probably	had	a	series	of	them	and	I	just	went	right	through	them.			
so	Thomas	Edison	was	pretty	exciting	because	I	could	do	things	that	he	did.	You	
know,	I’d	make	a	Morse	code	set.	So	that	was	an	interesting	story.	And	then	a	few	
years	later	I	read	one	called	‘Brother	Surgeons’.	Actually	I	read	about	the	Mayo	
brothers,	who	started	the	Mayo	Clinic.	And	that	was	in	a	Reader’s	Digest	-	Digest	
condensed	book.	So	the	condensed	novels	in	Reader’s	Digest.	My	life	was	pretty	
boring	as	a	kid,	and	I	used	to	read	this	stuff.		
So	you	could	get	through	the	story	in	a	night.	So	I	read	about	the	Mayo	brothers	
and	they	were	pretty	exciting.	They	used	to	operate	on	their	puppy,	and	then	they	
grew	up	and	started	the	Mayo	Clinic	about	1910,	I	think	it	was.	An	interesting	thing	
is	that	the	biggest	disease	in	the	United	States	was	actually	ulcers	and	stomach	
cancer	in	those	days.	And	so	the	Mayo	Clinic	was	actually	built	on	the	top	of	H.	
pylori.	If	it	wasn’t	for	H.	pylori,	they	never	would	have	bothered	starting	it,	because	
nearly	all	the	surgery	they	did	was	actually	stomach.	
I	mean	it’s	interesting	that	you	ended	up	in	H.	pylori.		
Yes.	
Is	there	a	direct	connection?		
Not	really.	The	other	one	I	read	was	Brother	Surgeons,	which	was	John	Hunter,	
William	and	John	Hunter.	And	William	Hunter	was	a	bit	more	studious	and	
academic,	and	he	had	a	museum	and	a	surgery	up	in	London,	up	in	Edinburgh.	And	
John	Hunter	was	his	rough	younger	brother,	who	probably	had	ADHD	or	
something.	Went	off	to	the	war,	and	used	to	do	nice	anatomy,	and	found	out	how	
to	cut	people’s	legs	off	in	five	seconds,	and	.	.	.	And	often	not	do	amputations	
because	he	knew	the	anatomy.	He	said	you	don’t	actually	have	to	cut	this	one	off	
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because	the	artery’s	still	there.	So	he	did	a	lot	of	important	stuff.	And	he	ended	up	-	
so	the	-	he	self	experimented	on	himself,	you	know.	His	theory	was	that	gonorrhoea	
and	syphilis	were	really	the	one	disease.	So	he	infected	himself	with	some	
gonorrhoea,	and	it	just	caused	a	pustule	on	his	arm,	I	think	that’s	all	it	was,	
maybe…	I	dunno,	maybe	he,	you	know,	did	the	real	thing.	,	But	the	story	is	that	he	
accidentally	also	infected	himself	for	syphilis,	with	syphilis.	Because	he	was	wrong,	
it	was	really	two	diseases.	And	the	syphilis	was	silent	until	he	dropped	dead	and	had	
a	massive	ruptured	aneurism	while	giving	a	lecture	when	he	was	seventy	-	seventy	
years	old.	That’s	the	s	-	the	folklore,	I	don’t	know	how	that	true,	how	true	that	was.	
He	probably	just	died	from	a	dissected	aneurism	or	something.	So	Brother	Surgeons	
is	a	great	story	about	these	two,	young	doctors,	young	medical	students,	who,	you	
know,	dug	up	bodies	for	the	anatomists	and	were	doing	all	this	stuff	in	18th	century	
England.	So	a	pretty	exciting	story.	So	I	had	those.	And	I	really	just	wanted	to	be	a	
GP.	Cos	I	-	in	Perth,	in	the	fifties	and	sixties,	you	could	be	a	GP,	or	maybe	you	could	
be	a	radiologist	or	something.	There	was	not	really	this	concept	of	medical	research	
.	.	.	I	never	had	it.	I	just	thought,	wow,	I	could	cut	and	sew	people	up,	you	know,	
surgery,	all	that	type	of	thing.	And	then	it	was,	when	I	got	into	medicine,	then	I,	
then	they,	then	I	realised	there	was	a	very	interesting	intellectual	problem-solving	
part	of	it.	
Mm.	
So	it	was	like	an	Agatha	Christie	novel.	If	you	could	put	the	clues	in	the	right	place,	
you	could	connect	it	all	back	to	one	illness.	So	you	might	have	five	different	things	
the	patient’s	telling	you,	and	some	weird	signs.	But	if	you	know	your	stuff,	you	can	
say,	well	one	disease	actually	explains	this,	this,	this,	this	and	this.	And	that’s,	that	
was	the	joy	of	medicine	for	me.	And	that’s	internal	medicine.	So	everybody	said	
‘what	is	internal	medicine?’	Well,	you’re	a	doctor	but	you	don’t	do	surgery.	Not	
usually.	‘Ooh,	that	must	be	boring.’	Well	of	course	it’s	actually	pretty	interesting,	
cos	that	is	the	intellectual	side	of	medicine.		
So	you’re	talking	of	when	you,	once	you	get	into	your	career,	once	you	start	to	go	
down	a	certain	path,	other	ideas	about	it	open	up	to	you.	Were	there	particular	
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mentors	or	role	models	you	had	as	you	went	through	your	career,	who	you	think	
were	instrumental	in	you	ending	up	where	you	did?	
Well,	whatever	type	of	medicine	I	did,	so	in,	in	your	internship,	you	do	something	
different	every	three	months,	so	that	you’ve	had	a	broad	experience	for,	so	you	do	
that	for	two	years.	Whatever	I	did,	I’d	come	home	and	say	this	is	fantastic,	this	is	
what	I	want	to	do,	this	is	the	best	kind	of	medicine,	so	exciting	and	interesting.	And	
so	after	two	years	of	that,	it	became	obvious	to	me	it	didn’t	matter	what	I	did,	that	I	
would	enjoy	it.	And	I	then	steered	away	from	surgery	and	away	from	obstetrics	and	
gynaecology	because	I	felt	it	was	too	easy.	Like	the	patient	comes	in	with	
appendicitis,	you	cut	his	appendix	out,	the	next	day	he’s	better,	and	the	third	day	or	
fourth	day	he	goes	home.			OBGYN	was	kind	of	the	same.	Some	woman,	she’s	going	
to	have	a	baby.	You	get	the	baby	out.	It’s	all	over.	Everybody’s	happy.	It’s	great,	
wonderful	outcome.	So	I	could	see,	it	seemed	to	be	that	that	was,	you	know.	There	
didn’t	seem	to	be	enough	to	it.	I’d	say	well	out,	over	the	last	two	thousand	years,	
people	have	figured	out	how	to	deliver	babies,	there’s	not	much	else	that	you	could	
write	about.	It’s	a	natural	process,	you	know,	so,	it	was,	it	seemed	to	be	limited	to	
me.	So	it	wasn’t	as	challenging.	So	I	went	-	headed	off	to	internal	medicine,	and	so,	
tough	stuff	like	diabetes,	vascular	disease,	hypertension,	renal	failure.	They	were,	
you	could	never	ever	learn	it	all.	It	was	continually	evolving	and	changing.	And	
being	able	to	take	a,	to	develop	rapport	and	interact	with	the	patient,	cos	I	-	I	
realised	early	on	that	90%	of	the	work	was	talking	to	the	patient,	and	getting	the	
patient	to	want	to	tell	you	everything	that	you	needed	to	know.	And	so	then	I	would	
-	and,	I’ve	always,	said	this	in	tutorials	with	the	patients,	with	the	med	students.	
After	you’ve	taken	the	history	off	the	patient,	90%	of	the	time,	you	already	know	
what	you’re	gonna	find.	And	then,	so	when	you	put	your	stethoscope,	the	
stethoscope	on	the	patient’s	chest,	you,	you	are	listening	for	that	one	little	click	or	
one	little	murmur	that	you’ll	hear	in	about	three	seconds,	because	this	is,	this	is	the	
answer	to	the	problem.	You’re	not	putting	it	on	saying	I	wonder	what	I’m	going	to	
find,	ooh	what’s	that.	You	know,	you	should	already	know	what	you’re	going	to	
hear.	And	that	tells	you	you’re	doing	the	right	job.			so,	that	was	where	I	wanted	to	
be	in	medicine.	And	I	wasn’t	obsessional	enough,	so	I	was	never	perfect	in	any	one	
specialty.	And	I	actually	used	to	like	geriatrics,	because	the	patients	had	six	things	
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wrong	with	them.	And	so	you	could	actually	work	on	six	diseases	at	once.	So	it	was,	
I	used	to	find	geriatrics	quite	exciting!	
That’s	a	funny	thing	about	geriatrics.	A	specialist	in	geriatrics	said	he	got	into	it	
for	a	similar	reason,	which	was	that	the	only	time	of	life	where	the	medical	
specialists	are	allowed	to	understand	all	these	different	diseases.	
Mm.	
And	you	need	to	understand	the	whole	body…	
And	you	actually	feel	that	tension	because	you	fix	up	one	thing	and	it’s,	something	
will	break	somewhere	else.	
Mm.	
You	wouldn’t	want	to…	for	instance,	someone	comes	in	with	a	high	blood	pressure,	
say	it’s	two	hundred.	Well	they’ve	probably	been	running	on	a	hundred	and	seventy	
for	the	last	ten	years.	So	you	don’t	want	to	bring	it	down	to	a	hundred	and	twenty,	
otherwise	you’ve	got	a	stroke	on	your	hands.	So	you	would	say,	well,	okay	I	
understand	that.	Let’s	just	bring	it	down	gradually	over	the	next	three	or	four	days	
cos	this	person’s	used	to	it.	And	thyroid	trouble,	you	don’t	just	give	them	a	full	dose	
of	thyroid,	you	start	them	off	at	tenth	the	normal	dose,	because	they’ve	had	it	for	
ten	years,	that	type	of	thing.	Otherwise	something	else	will	go	haywire.	
Mm.	
So	it	is	very,	very	interesting	medicine.	So	I	was	quite	happy	to	go	into	geriatrics,	
and	that’s	when	I	came	across	the	Helicobacter	thing.	
Oh,	right.	
Which	was	fun	in	a	different	way,	so	I,	I	found	out	that	I	really	had	to	do	it	myself,	
nobody	was	going	to	take,	take	it	over,	and	hand	it	to	me	on	a	plate,	and	say	‘you	
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can	do	your	normal	career	and	you’ve	discovered	the	cause	of	ulcers	as	well’.	I	-	you	
know,	it	was	a	battle	at	that	point,	and	somebody	had	to	fight	it.	Because	it	was	life	
and	death	for	various	people,	I	was	prepared	to	do	it	myself.	I	said	there’s	nothing	
that	I	can	think	of	that’s	more	important	than	focusing	on	the	H.	pylori	issue,	and	
getting	that	out	of	the	way.	
There	was	something	in	the	story	you	mentioned,	I	think	it	was	the	brothers,	the	
surgeon	brothers	.	.	.	
Mm.	
About	their	self-experimentation.	
Yes.	
And	that’s	a	big	factor	in	the	whole	H.	pylori	story.	
Mm.	
And	I	spoke	to	Frank	Fenner	recently	as	well,	who	obviously	as	you	know	was	
involved	in	Myxo	self	experimentation.	
Right.	So	his	experiment	sounds	particularly	scary	to	me!	Imagine	having	a	brain	
virus	or	something!	
But,	I	mean,	nevertheless	you	guys	went	out	there	and	—	
Well	it’s	actually	confidence	in	your	own	ability	to	assess	new	advances	in	science.	
Mm.	
So	you	see	something	and	someone	says,	and	you	talk	about	it,	or	you	try	to	write	it	
up.	And	it’s	only	one	case,	or	something	that	you	did,	and	it	seems	to	make	sense.	
Well,	of	course	the	editors,	most	people	would	go	and	say	well,	you	know,	it’s	
anecdotal.	It’s	your	opinion	about	it.	And	so	you,	you	step	back	a	bit	and	say	well	
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am	I	a	complete	idiot?	Or	did	this	really	happen?	And	I	say	well,	I	saw	this	guy,	he	
had	ulcers.	He	seemed	like	a	normal	person.	He	told	me	he	always	had	ulcers	every	
wintertime.	And	I	gave	him	antibiotics	and	got	rid	of	this	bug,	and	two	years	later	
he	tells	me	he’s	fine,	and	it’s	the	best	thing	he’s	ever	had.	So,	am	I	going	to	believe	
him	or	not?	Once	that’s	happened	to	you	two	or	three	times	and	you’ve	got	this	
story	—	
Mm.	
Well	you	say	well,	you	know	I’m	not	imagining	it.	There’s	something	going	on	here	
that’s	related	to	the	antibiotics.	So	you	have	to	have	that	confidence.	So	with	Frank	
Fenner,	or	with	me,	say	take	Frank,	he	does	ten	years	of	research	into	viruses.	And	
he	knows	all	this	stuff	about	it.	He	knows	that	this	cannot	infect	humans.	He’s	had,	
you	know,	all	kinds	of,	he’s	been	playing	with	it	in	his	lab,	eating	his	lunch	in	the	lab	
probably.	
Mm.	
Because	in	those	days	you	never	cared	too	much	about	that.	
Mm.	
Sucking	blood	samples	up	through	pipettes,	so	that	he	would	have	been	totally	
contaminated	with	these.	So	when	they	did	the	experiment	and	took	the	Myxo	
virus,	they	were	probably	immune	to	it.	Cos	if	it	did	infect	them,	they	probably	
caught	it	ten	years	ago.	Anyway,	so	the	whole	experiment	was	rubbish.		
Mm.	
They	could	have,	they	could	have	got	the	wrong	answer.	(Laughs).	And	said	it	
doesn’t	affect	humans,	and	then	the	whole,	half	the	Australian	population	could	
have	been	decimated	from	it		
Mm.	
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Because	they	were	already	immune,	cos	they’d	worked	with	it,	see.	
Mm.	
So	that’s	the	down	side	of	self-experiments		
So,	did	you	know	that?	
We	tried	we	tried	to	keep	that	quiet.	(Laughs)	
Yes!	That’s	really	interesting.	You’re	quite	right.	
Yes.	
It’s	a	PR	stunt!	
However,	at	the	time,	it	obviously,	you	know,	was	an	important	discovery	that	they	
made.	And	you	didn’t	want	the	whole	population	becoming	paranoid.	They	couldn’t	
do	anything	about	it	anyway.	So	from	what	they	knew,	it	was	a	safe	experiment	and	
they	went	ahead	and	did	it.	And	they	say	it’s	pointless	telling	people	it’s	safe	if	we	
haven’t	got	any	proof	and	we’re	not	prepared	to	do	it	ourselves.	Otherwise	no	one	
will	believe	us.	So	I	can	see	a	number	of	reasons	that	justified	that.	Now	in	my	own	
experiment,	I	had	by	1984,	Robin	and	I	had	been	working	on	this	thing	for	three	
years.	So	we	treated	a	lot	of	people.	I	treated	people	successfully	with	antibiotics.	I	
knew	which	antibiotics	worked	and	which	didn’t.	I	was	pretty	confident	that	I	
would	be	able	to	get	rid	of	this	bug	if	I	had	to.	Cos	I	had	treated	some	people.	So	on	
that	-	and	the	other	thing	that	I	found	out	that	year	was	that	forty	per	cent	of	blood	
donors	at	Fremantle	Hospital,	at	the	Red	Cross	in	Fremantle,	had	H.	pylori,	
according	to	my	serology,	the	blood	tests	I	did.	So	they	had	antibodies	against	the	
bacteria,	and	I	couldn’t	believe	it	at	first,	but	whenever	I	tested	them	they	came	up	
positive,	when	we	did	the	endoscopy.	So	I	said	well	hang	on	a	minute,	how	can	be	
that	forty	per	cent	of	the	population	of	Fremantle	has	it?	They’re	all	Italians	and	
Greeks	et	cetera,	so	that’s	a	hotspot	for	Helicobacter.	
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Mm.	
So	I	said,	probably	nothing’s	gonna	happen	when	I	take	it.	So	I	didn’t	expect	to	get	
unwell,	and	I	went	ahead	and	did	it.	But	also	I	did	a	careful	study.	I	took	a	baseline	
sample	and	a	biopsy	showed	that	I	didn’t	have	it.	And	so	my	colleagues	were	
looking	at	the	samples.	I	drank	the	bacteria.	I	recorded	what	was	going	on.	And	
then	we	took	the	scope	down	a	couple	more	times	and	took	biopsies	and	showed	
that	germs	had	infected.	And	it	showed	all	these	white	cells	invading	my	stomach	
and	trying	to	eat	the	germs,	eat	the	bacteria.	So	it	couldn’t	be	psychosomatic.	You	
couldn’t	do	that	just	by	knowing	about	it	or	being	frightened	or	stressed	or	
something.	So	I	said	this	is	what	you	see	in	ulcer	patients.	And	look,	it’s	happened	
in	my	stomach,	except	worse,	during	the	acute	infection.	So,	you	know,	I	don’t	
know	how	I	could	produce	white	cells	going	to	the	lining	of	my	stomach,	eating	the	
bacteria,	unless	the	bacteria	for	harm	were	harmful,	and	that’s	my	immune	system.	
Mm.	
So	it	became	a	bit	believable	then.	But	the	down	side	of	this	kind	of	thing	is	that,	it	
was	it	was	on	Michael	Moseley’s	Medical	Mavericks	shows.	And	he	would	
regurgitate	some	of	the	Helicobacter	story.	But	one	of	the	stories	that	is	true	is	a	
guy	called	Max	von	Pettenkofer,	and	he	was	the	Minister	for	Health	in	Germany,	in	
charge	of	infectious	disease	in	the	19th	century.	And	so	when	Robert	Koch	
discovered	the	cholera	bacteria,	and	they	said	this	is	the	germ	that	causes	cholera,	
von	Pettenkofer	said	it’s	not	true,	it’s	harmless,	and	to	prove	it,	I’m	gonna	drink	the	
bacteria.	So	he	drank	cholera	bacteria	out	of,	you	know,	somebody’s	diarrhoea	or	
something.	Don’t	ask	me	how	he	got	it.	
He	drank	the	cholera	bacteria,	and	he	didn’t	have	an	illness!	We	know	now	that	not	
everyone	with	cholera	dies	from	it	or	has	is	unwell.	You	know,	a	lot	of	people	are	
asymptomatic.	So	he	was	asymptomatic,	he	published	his	research,	told	everybody	
in	Germany	they	didn’t	really	need	to	worry	about	dirty	water.	Thousands	of	people	
probably	died	of	cholera	over	the	next	ten	years	until	they	eventually	said,	you	
know,	he’s	just	an	old	scientist,	he	doesn’t	know	what	he’s	talking	about,	he	may	be	
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Minister	for	Health	but	he’s	hopeless.	And	everybody	started	having	clean	water	
after	that.	
	
Mm.	
But	for	some	years,	a	lot	of	people	didn’t	worry	about	dirty	water	because	of	Max	
von	Pettenkofer’s	self-experiment.		
So	did	you	know	about	that	experiment	before	you	did	yours?	
No,	I	didn’t	know	about	it.	Ha	ha!	
(laughs)	
So	I	probably	would	have	been	very	paranoid.	I	would	have	had	to	do	it	on	myself	
several	times.	But	after	I	did	it,	there	was	a	doctor	in	New	Zealand	that	did	exactly	
the	same	thing.	
Mm.	
Got	the	same	results.	
With	H.	pylori?	
Yes.	Yes,	and	he	couldn’t,	he	tried	to	treat	himself	-	he	couldn’t	get	rid	of	it	for	three	
years	—	
(gasps)	Do	you	know	who	that	was?	
—	so	he	was,	he	was	unwell.	He	was…I	can’t	think	of	his	name.	He’s	probably	a	
professor	now	in	Auckland	of	infectious	disease.	
I’ll	look	him	up.	
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Russell	Morris.	Arthur	Morris.	Russell	Morris	is	a	rock	singer.	Arthur	Morris.	So	if	
you	search	Arthur	Morris	Helicobacter.	
Yes.	
You’ll	probably	pull	him	up	on	his	web	page.	
Yes.	Yes.	It’s	interesting.	Why	didn’t	you	–	or	maybe	you	did,	I	don’t	know	–	why	
didn’t	you	do	a	study	with	more	people	in	it?	Or	an	experiment	with	more	people	
in	it?	
Oh,	the	question	was,	would	it	be	passed	by	the	ethics	committee?	
Yes		
So	realistically.	.	.	
(Laughs)	
It	would	have	taken	me	six	months	to	be	approved	and,	you	know,	I	would	have	had	
to	have	funding	from	NHMRC.	
Mm.	
They	hated	my	research,	in	those	days.	So	I	just	needed	to	answer	this	question.	So	
I	had	been	talking	about	it,	giving	grand	rounds	about	these	bacteria	and	
antibiotics.	I	hadn’t	-	I’d	had	no	double	blind	study	at	that	stage.	I	had	no	animal	
model.	And	so	I	didn’t	really	didn’t	have	a	leg	to	stand	on	scientifically.	So	I	said,	
am	I	going	to	spend	the	rest	of	my	career	trying	to	chase	this	ulcer	bug,	or	is	it	
really	a	commensal?	So	I	have	to	just	do	the	definitive	experiment.	So	it’s	a	good	
example	of	testing	your	own	hypothesis.	So	if	you	if	you’ve	got	a	new	theory,	you	
have	to	be	prepared	to	do	the	experiment	that’s	going	to	prove	that	you	are	wrong.	
You	pray	that	it’s	not	gonna	work.	You	pray	that	you’re	going	to	be	right,	but	you	
actually	have	to	test	your	own	hypothesis.	So	say	if	so	here	I	am,	at	the	end	of	my	
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medical	training.	I’m	going	to	go	off	into	geriatrics	or	somewhere	into	private	
practice	if	nothing	happens.	If	I	get	-	if	I	develop	gastritis	as	we	would	expect	from	
what	we	know	about	this	bug,	then	that’s	where	I’m	going	to	go.	I’m	going	to	go	
into	research	and	follow	this	up	cos	it’s	too	important	to	let	it	drop.	So	that	little	
experiment	I	did,	I	was	sitting	at	a	junction	in	my	career.		
Mm.	
I’m	going	to	be	a	comfortable	private	practitioner	whatever,	or	I’m	going	to	be	some	
masochistic	researcher	who	is	going	to	spend	a	lot	of	time	trying	to	get	papers	
published.	A	lot	of	suffering	there.	
Mm.	
And	so	I	took	that	avenue	and	it	turned	out	okay.	But	it	really	-	the	first	ten	years	
was	pretty	tough.	And	it	was	tough	on	my	family,	on	my	colleagues.	Because	
obviously	if	you,	every	time	you	see	Barry	getting	rejected	or	failing	at	some	project,	
you	say,	‘oooh,	you	know,	I	feel	for	him,	he’s	such	a	nice	guy’.	(Laughs)	
(laughs)	
But	I	was	loving	it,	so	I	like	a	good	fight.	(Laughs)	So	it	never	really	bothered	me.	
No.		
Because	you	only	have	to	have	one	or	two	patients	that	you	really	make	a	difference	
to.	
Mm.	
And	you	say	that	didn’t	happen	by	chance	-	I	know	that	eventually	I’m	going	to	be	
out	there	and	everyone’s	going	to	say,	‘would	you	like	to	write	the	chapter	in	my	
textbook	about	ulcers?’		
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Mm.	
And	it’s	going	to	be	about	these	bacteria.	So	I	then	spent	ten	years	writing	chapters	
until	I	got	burned	out!	And	-	well	I	don’t	hate	it,	I	still	write	chapters,	but	I	have,	I	
can	tell	you	I’ve	got	several	chapters	I	have	to	write,	usually	about	the	same	thing.	
Were	you	always	a	great	communicator?	
I	think	I	was.	I	think	I	could	always	do	an	interesting	interview.	I	must	have	some	
Italian	blood	in	me	I	think.	(Laughs)	
(Laughs)	
Actually,	well,	it’s	a	skill.	I	don’t	necessarily	know	I	could	do	it	initially.	But	in	the	
United	States	people	who	were	in	media…	I	never	did	any	drama	or	acting,	but	
people	in	media	told	me	things,	which	I	hadn’t	realised	before.	And	one	of	the	things	
that	you	we	should	tell	doctors	is	that	you	cannot	speak	with	inflection	in	your	
voice	if	you	keep	your	hands	still.	So	if	you	put	your	hands	under	the	table	and	don’t	
move	them,	your	voice	will	be	boring.	But	I	learned	very	quickly	that	if	you	free	up	
your	hands	to	use	a	bit	of,	you	know,	gesturing	during	any	kind	of	conversation,	
even	if	it’s	a	phone	conversation,	it’ll	be	ten	times	more	interesting.	And	so,	I	
someone	did	a	practice	run	with	me	once	on	a	talkback	show,	and	told	me	that.	
And	so	then	I	was	doing	a	call	in	talkback	show	on	the	radio	so	with	Russell	one	of	
the	talk	time	guys,	as	long	as	I’ve	got	my	hands	free	I	know	I’ll	sound	interesting.	
But	if	I	sit	there	with	my	hands	in	my	pockets,	I	just	become	boring.	And	most	
doctors	don’t	realise	that.	A	bit	frightened	of	the	cameras	so	they’re	not	moving,	
and	they’ll	talk	away,	and	it’s	just	dead	boring.		
Yes	-	that’s	a	really	interesting	connection	between	the	body	and	that	physical	
expression.	
Gotta	get	your	hands	out.		
Yes.	
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Have	them.	And	so	often	playing	with	something	like	having	a	pen,	you	know,	
holding	something,	its	makes	the	interview	much	more	interesting	on	camera.	Even	
if	your	hands	aren’t	actually	in	the	picture.		
Mm.	Yes,	that’s	a	really	good	point.	I	think	the	same	probably	applies	to	when	
you	give	a	public	talk	or	a	lecture.	
That’s	true.	I	can	give	a	lecture	anywhere	and	it	sounds	interesting.	And	it’s	just	
because	I	know	how	to	talk.		
I	wanted	to	ask	you	-	we’ve	talked	a	bit	about	people	-	well,	you’ve	spoken	a	bit	
about	people	writing	to	you,	and	it	sounds	as	though	the	large	bulk	of	that	has	
been	people	with	ulcers,	or	you	know,	someone	with	an	ulcer	--	
Yes.	
--	who’s	concerned	about	the	medical	side	of	things.	Do	people	write	to	you	
about	other	stuff	or	contact	you	about	other	things.	
People	with	weird	undiagnosed	diseases	often	write	to	me.	
(Laughs)	
Saying	‘Dr	Marshall	can	you	do	some	research	on	this?’		
Mm.	
I	say,	well,	I	know	of	a,	have	a	look	on	the	National	Institutes	of	Health	research	
clinical	trials	research	web	page	and	see	if	you	can	find	connect	up	with	somebody	
there,	cos	at	least	they’ll	know	all	about	it.	So	usually	these	days	you	can	find	
something	on	the	Internet.	No	matter	how	rare	your	disease	is	you	can	find	a	club	
of	really	weird	rare	people	that	you	can	talk	to.	And	then	you	never	know.	You	
might	find	out	there	are	thousands	of	these	people.	So	I	s’pose	things	like	autism,	
colitis,	what’s	the	new	one	-	Asperger’s	syndrome	I	hear	about.	
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Everywhere.	
It’s	because	of	that	ABC	show	where	that	doctor’s	got	it	and	he’s	horrible	to	his	
patients	and	they	all	love	him.	(Laughs)	Every	doctor’s	dream!	What	is	that	called?	
House?	
No,	it’s	not	-	House	is	like	that.	Okay	House	is	another	version,	but	the	English	guy	
who	lives	in	the	country	-	he	leaves	London	and	goes	to	this	real	weird	little	fishing	
village.	
Oh	yes,	yes!	What’s	his	name,	I	can’t	remember	the	name	of	the	character.	
(To	assistant)	Chris,	who’s	the	character	with	Asperger’s	syndrome?	
Yes,	I	can’t	think	of	it	either.	I	know	the	show	you’re	talking	about.	Yes,	
yes.	
He	hates	his	patients	and	he’s	always	abusive	to	them.	
Yes!	
Every	doctor’s	dream.	So	I	do	a	bit	of	that.	I	remember	over	the	years	someone’d	
come	in	and	say	well	one	of	the	interesting	things	about	this	Helicobacter	is	that	
men	will	get	ulcers.	It’s	a	male	sort	of	disease.	Cos	they	have	a	higher	acid	level	and	
maybe	they	smoke	more,	was	the	other	thing.	And	women	with	Helicobacter	often	
would	never	have	an	ulcer.	And	so	they’ve	have	a	barium	meal	or	investigations	for	
the	same,	exactly	the	same	symptoms.	They’d	feel	nauseated,	gnawing	sensation	et	
cetera,	and	they	wouldn’t	have	an	ulcer.	They’d	have	no	excuse	for	slacking	off	and	
not	feeling	well.	And	so	they	would	get	labelled	as	being	psychoneurotic.	So	if	you	
were	a	man	with	an	ulcer,	oh,	you’re	an	ulcer	personality,	you’re	under	a	lot	of	
stress,	you’re	the	money	earner,	all	that	good	macho	stuff.	If	you’re	the	same,	if	
you’re	this	guy’s	wife,	you’re	working	twice	as	hard,	with	all	these	kids	and	your	life	
is	chaos,	and	you	feeling	sick,	and	you’ve	felt	sick	since	your	age	fifteen.	You	never	
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knew	what	was	wrong	with	you,	and	nobody’s	got	any	sympathy.	You’re	just	mad;	
you’re	just	on	antidepressants	or	something.	So	I	soon	had	a	clientele	of	that	sort	of	
patient.	So	it	was	fun,	actually,	cos	I	saw,	I	was	happy	to	do	geriatrics,	but	I	ended	
up	with	a	lot	of	young	women	coming	into	my	practice	because	they	wanted	to	
someone	to	have	a	look	at	them,	and	say,	‘I’m	sure	there’s	something	wrong	with	
me.	Dr	Marshall,	all	my	doctors	just	say	I’m	mad.	What	do	you	think?’	I’d	say	‘well	
I	think	you’re	mad	too,	but	let’s	do	an	endoscopy	and	see	if	you’ve	got	a	germ	in	
your	stomach,	because	if	you’ve	got	that,	I	couldn’t	care	if	you’re	mad	or	not,	I’ll	
give	you	some	antibiotics.	I	mean,	I’m	not	a	psychiatrist’.	So	I	used	to	have	fun	sort	
of	interacting	with	these	women,	and	quite	often	they	would	have	something	
genuinely	wrong	with	them	that	had	been	missed.	And	if	they	were	mad	I’d	say	‘well	
look,	you’re	fifty	years	old	and	you’re	mad,	I’m	not	going	to	be	able	to	fix	you,	get	
used	to	it’.	(Laughs)	
(Laughs)		
You’ve	coped	for	fifty	years,	probably	you’ll	be	okay	for	the	next	fifty.	And	I’m	I	still	
have	patients	like	that.	
Yes.	
So	often	you	can’t	fix	people.	Can’t	fix	everything.	
No,	and	I	s’pose	you	can’t	try	to	either.	
So	someone	has	a	strange	personality,	well	.	.	.	
Mm.	
You	do	your	best.	But	you	shouldn’t	be	too	depressed	about	not	being	able	to	cure	
them,	because	there’s	so	many	things	you	can’t	cure.	
Mm.	That	sense	of	enjoyment	you	get	from	your	work	is	really	apparent	--		
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Mm.	Mm.	
--	and	I	wondered	if	you	could	talk	a	bit	about	what	makes	you	a	good	doctor.	
And	what	makes	you	a	good	medical	researcher.	
Well	as	I	said	I	sort	of	steered	away	from	those	easy	areas	of	medicine.	Because	I	is	
I	felt	that	it	was	maybe	a	bit	too	easy	and	a	bit	too	the	same.	And	I	didn’t	
necessarily	steer	away	deliberately	away	from	general	practice.	But	there	were	a	few	
years	in	the	seventies	and	early	eighties	I	think	where	a	lot	of	people	who	were	
smart	found	themselves	in	general	practice	and	it	was,	it	was	becoming	a	bit	
boring.	Every	sore	throat	was	the	same,	you	know,	and	the	government	said	you	do	
this	and	this	and	write	the	prescription.	And	so	what	do	you	do	with	your	life?	
You’re	sitting	there	day	after	day	doing	the	same	thing.	A	lot	of	people	became	
bored	with	general	practice.	So	that’s	what	I	would	worry	about.	Of	all	the	things	I	
fear,	is	boredom.	
Mm	
And	I	will	actually	do	something	crazy	or	irritate	somebody	just	to	get	some	
feedback.	Just	to	get	something	interesting	happening,	some	kind	of	interaction.	So	
I	get	that	from	the	patients	and	nothing	makes	me	happier	than	having	an	
incurable	patient	who	sits	there	and	tells	me	their	life	story	for	thirty	minutes.	I’m	
quite	happy	to	listen	to	that.	Maybe,	maybe	get	involved	with	it	vicariously.	
(Laughs)	
(Laughs)	
So	I	have	patients	like	that.	And	I	will	maybe	get	nowhere	over,	and	I’m	maybe	an	
hour	late	in	my	clinic	et	cetera,	but	I’ll	probably	come	home	quite	interested	with	
some	interesting	details	and	quite	a	satisfied	feeling	after	over	the	day’s	work.so	
nothing’s	more	annoying	to	me	however	than	sitting	standing	in	a	line	because	of	
some	inefficiency,	and	there’s	less	of	that	in	Australia	now.	But	I	can	tell	you	over	
the	last	twenty	years	that	there’s	been	a	lot	of	that	in	Australia,	and	it’s	because	
people,	maybe	people	are	not	aware	of	what	the	international	standard	is.	You	don’t	
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necessarily	have	to	invent	reinvent	the	wheel	on	everything,	and	there’s	some	good	
things	we	do	great	in	Western	Australia,	for	instance,	that	maybe	they	don’t	do	in	
Melbourne	or	Sydney,	or	they	do	it	differently.	And	you	would	say	well	they	do	it	
differently	over	there,	and	then	you	can	say	is	it	better	or	not?	And	you	can	make	a	
decision.	And	so	you	can	be	independent	over	here	and	be	a	bit	experimental.	
Yes.	
But	you	don’t	want	to	be	‘this	is	how	we	do	it	here,	and	we	don’t	want	to	know	
about	anything	else’.	So	that	attitude	annoys	me.	
So	it	sounds	as	though	you’re	quite	an	open-minded	inquisitive	kind	of	a	person	
really.	
Right,	I’ll	be,	I’ll	look	out	for	things	that	make	anything	more	efficient.	
Mm.	
And	so	I’m	always	very	interested	in	technology.	I’d	say	that	in,	say	in	Australia	or	
Western	Australia,	cell	phones	have	probably	doubled	our	productivity.	Except	if	
you’re	in	a	trade.	You	know,	if	you	were	laying	bricks	or	a	carpenter	or	something	
like	that,	your	cell	phone	will	help,	maybe	you	can	find	out	where	to	go	and	get	a	
saw	blade	without	actually	driving	round	to	ten	Bunnings-es	till	you	find	the	one	
you	want.	So	it	helps	everybody.	But	for	academic	pursuits	and	business	and	
everything	you	can	run	your	business	in	your	car	at	home,	all	kinds	of	things.	So	I	
would	say	in	medicine	it’s	the	same.	And	I	think	ultimately	people	will	just	do	more	
and	more	stuff	on	the	Internet	and	over	the	phone.	A	lot	of	things	you	do,	you	
could,	you	have	an	Internet	doctor	doing	it	for	you.	
Yes,	for	sure.	It	seems	to	have	really	changed	the	way	we	have	our	relationship	
with	medicine.	
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Yes	well	I	haven’t	seen	it	being	properly	billed	for	in	Australia.	One	of	the	things	
that	I	said	to	get	anything	new	in	health	in	Australia,	you	have	to	find	some	
connection	to	the	funding	and	the	bureaucrat.	
Mm.	
They’re	-	every	time	he	releases	more	funding,	he	gets	demoted.	He	only	gets	
promoted	if	he	spends	less.	So,	if	you	say,	well	I	can,	you	know,	a	lot	of	people	are	
calling	up	the	hospital	trying	to	find	out	about	flu,	why	couldn’t	you	take	their	
Medicare	number	and	charge	five	dollars	and	then	have	a	person	who	is	occupied	
24	hours	a	day	just	helping	the	community	doing	that.	Well	you	can’t	do	it,	because	
there’s	no	way	of	actually	paying	that	person’s	salary.	You’ve	gotta	go	begging	to	
the	health	department	or	somewhere	to	do	it.	They’ll	say	we	haven’t	got	enough	
nurses,	you	know,	that	type	of	thing.	Whereas	in	the	US,	someone	says	there’s	a	
need,	I’m	going	to	start	it	up	and	I’ll	charge	for	it	and	it’ll	be	a	business	and	
everyone’ll	say	it’s	great.	And	it	happens	twice	as	fast.	So	there’s	ups	and	downsides	
of	the	way	you	organise	your	healthcare.	
Yes,	definitely.	I’ve	just	got	two	more	questions.	The	first	one’s	gone	completely	
out	of	my	head.	So	I’ll	go	with	the	second	one.	Which	was	about	whether	you	
have	advice	for	young	researchers	following	in	your	footsteps	after	everything	
you’ve	learned	about	how	systems	work	internationally	and	nationally,	after	all	
your	experiences.	
	Okay.	Well	I	learnt	-	there’s	a	few	things	I’ve	learnt	only	gradually	over	the	last	few	
years.	I	would	say	try	and	do,	you	should	do	what	you	like.	And	there’s	a	number	of	
reasons	for	this.	If	you	don’t	like	it,	you	won’t	be	able	to	be	good	at	it.	You	won’t	put	
a	hundred	per	cent	effort	into	it.	If	someone	else	likes	to	do	it,	whatever	it	might	be,	
they	will	put	a	hundred	and	ten	per	cent	in	it	and	you	will	never	be	competitive	with	
that	person.	Whereas	if	you	like	to	do	something	very	weird	or	a	bit	strange	or	
esoteric,	I	can	think	of	a	million	projects	in	biology	for	instance	or	medicine	that	
you	could	focus	on,	and	everyone’d	say	well	why	do	you	want	to	do	that?	Well	the	
answer	is,	if	it	interests	you	and	it’s	difficult,	pretty	soon	you	have	no	competition.	
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And	before	you	realise	it,	you’re	the	world	expert	on	it.	So	in	medicine	there	are	
many	disgusting	areas	of	medicine	that	you	could	focus	on!	And	I’m	sure	there’d	be	
a	disease	somewhere	that	people	would	appreciate	having	some	interest		taken	in.	
Actually	one	of	my	side	projects	for	an	example	was	bad	breath.	
(Laughs)	
I	had	a	lot	of	fun	doing	research	into	bad	breath.	I	still	do	a	little	bit	of	it,	but	it’s	
not	in	the	medical	books.	But	for	people	who	have	chronic	breath	-	halitosis,	it	
ruins	their	life.	You	can’t	be	in	sales.		And	it’s	a	big	mystery.	People	really	don’t	
understand	it.	So	there	were	people	in	California	who	were	interested	in	it.	And	
there’s	some	bug	that	some	germ	that	they’ve	discovered	and	someone’s	patented	a	
treatment	for	it.	That	person	will	make	millions.	So	how	could	you,	you	know,	make	
a	living	out	of	bad	breath?	It’s	there,	there’s	plenty	of	people	who	have	it.	So	that	
would	be	one	thing.	So	if	it’s	difficult	and	a	bit	rare	but	you	enjoy	doing	it,	that’s	the	
perfect	thing	for	you	to	do.	Now	what’s	the	other	thing?	The	other	thing	I’d	say	-	
this	is	my	new	motto.	There’s	nothing	worth	doing	that	takes	less	than	two	years.	
(Laughs)	
So	in	my	career	everything,	every	project	I	think	up,	takes	at	least	two	years.	If	it’s	a	
one	year	project,	I	probably	it’s	probably	not	worth	it.	There’s	already	a	million	
people	doing	it.	Cos	a	lot	of	a	lot	of	things	particularly	in	your	academic	career,	
they	say	right,	you’re	gonna	do	honours,	or	you’re	gonna	do	masters,	or	you’re	
gonna	do	something.	You	know,	you	start	on	start	February,	you	do	a	bit	a	couple	
of	months	planning,	you	get	about	three	months	of	lab	work	for	instance,	and	then	
you	do	the	write	up	and	then	you	have	to	finish	it.	And	that’s	-	you	go	on	to	
something	else,	it’s	your	holidays	and	you	do	something	else	the	following	year.	So	
millions	of	little	quick	projects	are	being	done,	and	often	they,	you	know,	things	a	
bit	significant	need	a	bit	of	follow	through.	So	even	early	in	your	career,	probably	
you	need	to	be	in	a	two	year	time	span	early	on.	Cos	if	you’re	like	I	was,	I	probably	
am	still	naturally	I	try	to	get	things	finished	in	a	year.	You	cannot	do	it	and	it’s	very	
frustrating.	Especially	if	you’ve	got	ADHD	--	
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(Laughs)	
Or	creativity	as	I	call	it!	You	cannot	finish	anything.	It’s	great	being	a	Nobel	Prize	
winner	cos	then	you	can	set	up	a	team	and	you’ve	got	a	lot	of	people	trying	to	finish	
everything	for	you	and,	you	know,	get	the	best	bang	for	the	buck	on	the	Nobel	Prize	
for	instance.	But	I	have	to	say	that	early	on	in	my	career	it	was	so	frustrating,	cos	
even	when	I	discovered	H.	pylori	I	said,	I	suddenly	realised	this	causes	ulcers	-	what	
can	I	do?	Bad	luck,	Barry,	the	deadline	for	grants	was	last	week.	I	say	well	you	know	
I	can’t	work	on	a	deadline.	I	thought	of	this	-	I	only	thought	of	it	this	week.	I	didn’t	
know	this	a	week	ago.	So	why	can’t	I	get	funded	tomorrow?	Thousands	of	lives	are	
at	stake.	You	know,	of	course,	as	far	as	the	government	and	the	NHMRC	and	
everybody’s	concerned,	that	is	irrelevant.	We	work	on	slow	time	periods.	So	you’ve	
gotta	plan	it	for	six	months,	find	your	collaborators,	and	then	write	your	grant	for	
six	months,	and	then	it’s	ten	months	before	you	find	out	if	you’ve	got	it.	Or	eight	
months	or	something.	And	then	it	kicks	in	the	year	after	that.	Kind	of,	oh	my	god.	I	
could	never	do	that.	And	so	I	have	to	tell	you	that	my	success	in	writing	grants	is	
very,	very	poor.	I	probably	have	a	hit	rate	of	about	one	in	five.	But	luckily	when	I	
really	needed	one,	when	I	was	really	desperate,	I	probably	tried	harder.	So	that	you	
need	to	make	-	you	don’t	want	to	make	them	too	easy,	but	at	the	moment	I	think	
it’s	probably	too	difficult	to	get	research	grants.	
Mm.	
And	people	who	are	hopeless	at	writing	grants	like	me	don’t	get	them.	And	I	dunno	
what	they	do.	But	they	don’t	get	Nobel	Prizes.	Some	of	them	do.	
Some	of	them,	not	very	many.	
Yes.	But	maybe	they	are	the	ones	that	do	get	the	Nobel	Prizes	because	they	go	
through	another	pathway.	
Mm.	
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They’ll	find	a	short	cut.	And	then	they’ll	make	the	big	discovery.	So	I	made,	I	took	
many	shortcuts	and	probably	I	took	them	because	I	wasn’t	funded.	So	in,	you	know	
we	could	say	I’ve	just	suddenly	had	an	inspiration.	So	I	wasn’t	funded	in	the	
applications	I	put	in	at	in	1983	because	they	were	probably	hopeless	applications.	
I’d	probably	be	rather	ashamed	if	I	read	them	now.	So	I	was	taking	shortcuts	and	
doing	all	kinds	of	other	things,	and	one	of	the	things	I	did	was	I	drank	the	bacteria.	
I	treated	people	who	walked	in	my	door,	I	gave	them	some	antibiotics,	I	developed	a	
blood	test,	developed	some	diagnostic	tests.	So	I	had	about	five	research	projects	on	
the	go,	if	it	were	-	whereas	if	I	was	funded	I	would	have	had	to	come	to	work	at	you	
know	8am	every	morning	and	do	-	give	people	antibiotics	for	ulcers.	And	there	were	
ten	other	angles	I	would	have	had	to	ignore.	So	in	conclusion	the	best	thing	that	
ever	happened	to	me	was	I	didn’t	get	a	research	grant	in	1983.	It’s	probably	true.	
	
You’ve	just	reminded	me	of	a	guy	Doug	Prasher	–	he	was	in	the	group	of	
scientists	who	worked	on	the	fluorescing	gene	amongst	jellyfish.	
Oh	yes.	
And	he	is	the	poor	sod	who	kind	of	ran	out	of	post	doc	funding	and	dropped	out	
of	science	and	ended	up	driving	a	shuttle	bus	for	a	car	company	in	somewhere,	
deep	south	America.	And	his	research	is	incredibly	important	research	that	he’d	
done	that	he	hadn’t	managed	to	keep	going	with	--	
Yes.		
--	he	gave	it	to	some	colleagues	and	they	went	on	to	win	the	Nobel	Prize.	And	he	
didn’t	get	the	Nobel	Prize.	And	I	just	thought,	you	know…		
Ooh.	Well	actually!	
It’s	interesting	that	you	didn’t	end	up	like	that!	
		376	
Well	I’ll	tell	you	a	sad	story.	It’s	not	for	me.	But	Chris	have	we	got	a	Helicobacter	
book	here	somewhere?	Pioneers	book?	
Yes.	It’s	just	in	that	cupboard	there,	Barry,	it’s	there	or	the	one	beside	it.	
(Barry	finds	the	book)	Have	you	seen	it?	
No	
Helicobacter	Pioneers.	So	I’ve	been	hearing	these	sad	stories	over	and	over	again.	
We’re	down	to	our	last	few	copies	so	I	won’t	sign	it,	and	I’ll	just	loan	it	to	you!	
Okay.	
Then	you	can	read	it.	But	I	collected	all	these	stories	of	these	poor	people	who	
discovered	Helicobacter.	And	the	one	that	is	in	there	is	this	poor	Greek	physician	
who	discovered	that	ulcers	were	cured	by	antibiotics	in	the	sixties.	So	he	didn’t	have	
any	technology,	couldn’t	prove	it.	He	just	treated	thousands	of	people	with	ulcers	
with	antibiotics.	What	happened	to	him?	They	struck	him	off	the	register,	they	
deregistered	him	in	Athens	because	he	was,	you	know,	going	against	the	tide	and	it	
was	not	dogma,	the	dogma	said	other	things.	He	wrote	a	paper	that	was	rejected	by	
the	JAMA,	which	is	the	big	US	journal.	He	wrote	a	patent,	which	was	granted	in	
Greece	but	he	didn’t	have	the	resources	to	do	anything	else.	And	then	about	ten	
years	later	he	died.	He	wasn’t	totally	penniless	but,	and	he	was	still	running	a	
secret,	illegal	practice	on	the	side	I	think!	But	you	know.	It’ll	make	you	cry	when	
you	read	that	chapter.	Pass	it	and	I’ll	open	that	chapter	for	you.	If	that’s	the	only	
one	you	read,	that’d	be	the	one.	Likoudis…	It	was	about	1962.	That’s	him	-	John	
Likoudis,	general	practitioner	in	Greece	who	in	1958	discovered	the	aetiology	of	and	
the	treatment	for	peptic	ulcer	disease.	If	he	had	had	the	right	resources	and	if	he	
was	in,	say,	if	he	lived	near	the	Mayo	Clinic	or	someone,	they	would	have	discovered	
the	cause	of	ulcers	about	five	years	later	and	he	would’ve	won	the	Nobel	Prize	
twenty	years	ago.		
Yes.	
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But	actually	there	were	a	lot	of	people	before	him	that	missed	out	as	well.	
Yes.	It’s	fascinating	isn’t	it	-	the	timing	and	the	resourcing.	But	you	mentioned	
the	reaction	of	the	scientific	community	and	that	was	what	my	missing	question	
was	about.	That	sense	of	struggle	for	ten	years.	
Right.	
Going,	you	know,	swimming	against	the	stream.	Failing…	
So	you	can	say,	well	as	a	scientist	or	a	doctor,	you	can	be	confident	that	eventually	
the	truth	will	come	out,	and	if	it’s,	if	it	really	is	a	cure	for	cancer,	one	day	there’ll	be	
a	knock	on	my	door,	and	a	drug	rep’ll	come	through	the	door	with	a	glossy	
brochure	and	a	and	some	samples.	At	that	point	in	time	I’m	obliged	to	pay	
attention	to	it.	But	there’s	something	on	the	news	every	day	about	some	little	slimy	
little	bug	that	cures	cancer.	
Mm.	
Or	something.	A	new	herb	or	something.	So	you	can’t	possibly	be	an	expert	on	
every	single	one	of	those,	so	you	have	to	trust	in	the	system	to	a	certain	degree.	
However,	if	it’s	a	common	disease,	and	the	treatment	is	something	that	you’ve	got	
in	your	drawer,	amoxicillin	samples	for	instance,	a	lot	of	people	will	have	a	go	at	it	
if	they	hear	about	it.	So	that’s	where	the	media	is	connected.	
Mm.	
And	thousands	of	doctors	were	testing	out	my	treatment.	And	they’d	typically	test	
it	out	on	their	wives	and	mother	in	laws.	And	say,	god,	my	mother	in	law,	she	was	
so	cranky	until	I	gave	her	some	amoxicillin.	She	says	her	appetite	improved,	her,	
and	she’s	been	a	saint	ever	since.	You	know,	that	kind	of	story	would	come	back.	So	
the	media	did	that.	So	that	I	had	a	following	long	before	it	was	accepted	dogma	by	
doctors.	And	plenty	of	patients	would	have	turned	up	at	their	doctor’s	practice	with	
the	news	article,	and	said	I’d	really	like	you	to	try	this	on	me.	And	say	(grouchy	
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doctor	voice)	‘	that’s	rubbish,	I’m	not	gonna	try	that	on	you,	you	have	to	go	to	
someone	else.’	Well,	pretty	soon	the	doctor	in	that	town	who	did	treat	H.	pylori	had	
95%	of	the	patients.	Um.	I’ve	got	a	great	story	-	the	first	lecture	I	ever	gave	in	New	
York	City	was	1987.	So	I	arrived	in	the	US,	lo	and	behold,	someone	asks	me	to	come	
up	to	New	York	City	and	give	grand	rounds.	So	I	gave	grand	rounds.	And	there	was	
a	doctor	there	and	he	was,	it	was	the	day	before	he	left	and	went	into	private	
practice	as	a	gastroenterologist.	And	he	went	up	into	Connecticut.	And	I	met	him	
ten	years	later,	he	said	‘Barry	I’ve	got	the	biggest	practice	in	Connecticut,	cos	the	
day	after	I	went	to	your	talk,	you	told	us	about	this	little	test	that	had	been	
discovered	and	was	being	made	in	Western	Australia,	and	I	mail-ordered	it,	and	I	
wished	to	receive	it	in	brown	paper	parcels	because	it	was	illegal	to	import	it.’	And	
he	was	started	using	it	up	in	Connecticut.	And	all	these	ulcer	patients	from	miles	
around	plus	their	wives	who	had	dyspepsia	and	their	you	know	mothers	in	law	and	
everybody	were	all	turning	up.	And	so	if	he	was	on	easy	street	-	he	probably	drove	a	
Rolls	Royce	and	had	six	partners	and	things.	He’s	probably	retired	now.	Probably	
lives	in	the	Bahamas.	
All	because	of	the	brown	paper	bags.	
Yes.	Just	all	because	he	happened	to	go	to	my	lecture	and	was	convinced.	He’s	or	at	
least	he	said	‘you	know	I	should	try	that,	it	might	be	true.’	And	so	doctors	that	did	
that	were	actually	very	successful.	And	everybody	who	worked	for	me	in	the	US	
ended	up	having	a	great	practice	because	they	got	in	on	the	on	the	crest	of	the	wave	
with	the	Helicobacter.	
Yes.	
And	quite	often	there	were	big	group	practices,	and	they	would	say	well	this	is	
interesting,	why	don’t	we	hire	this	guy	and	get	him	as	a	new	partner.	Because	this	
appears	to	be	an	exciting	area.	So	that	these	guys	would	then	come	in,	and		you	
would	wonder	why	it’s	not	why	it’s	difficult	to	stay	in	hospital	practice,	in	university	
practice	in	the	US.	My	fellows,	well	they’re	registrars	in	Australia,	the	
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gastroenterology	fellows,	would	leave	and	go	straight	into	$250,000	salaries	in	
private	practice.	If	they	were	-	they’d	have	to	be	good.		
Mm.	
You	know,	they	were	pretty	sharp,	most	of	them.	But	of	course	they	had	to	-	they	
owed	a	hundred	thousand	dollars	for	their	university	degree,	the	debt	from	
university,	and	had	postponed	their	life	for	ten	years	at	that	stage	and,	but	it’d	only	
be	a	couple	of	years	and	they’d	be	building	a	mansion	and	having	a	nice	car	and	all	
that	kind	of	stuff.	So	that	was	secondarily	rewarding	for	me	to	see	that	happen.	
Yes,	sure.	But	it’s	just	interesting	hearing	you	talk	about	it,	that	that	undercurrent	
of	people	early	adopters,	people	hearing	about	it,	trying	it,	having	a	go.	
So	early	on,	they	would	always	delegate	the	Helicobacter	research	to	the	most	
hopeless,	junior,	unfunded	doctor,	from	Timbuktu	or	somewhere!	And	then	a	year	
later	they’d	notice	that	he	was,	he’d	published	a	little	paper,	he’d	be	getting	invited	
to	speak	at	important	lectures	and	conferences	et	cetera.	And	all	those	guys	are	
now	all	the	big	professors	in	the	United	States.	So	if	you	go,	if	I	go	to	the	US	now,	
I’m,	I’ll	be	invited	to	black	tie	dinner,	because	the	deans	and	the	chiefs	of	
gastroenterology	are	all	these	people	who	were	in	the	controversial	Helicobacter	
research	fifteen	years	ago.	Twenty	years	ago	now.	And	now	they’re	all	the	
professors	of	medicine!	
So	sometimes	the	risk	of	playing	in	an	area	that’s	unaccepted	is	definitely	pays	
off.	
Yes	the	other	thing	you	need	to	realise	is	that,	this	is	probably	one	of	my	third	
lessons	is	that	a	lot	of	these	things	we	know	in	medicine	are	really	like	a	religion.	So	
you	get	them	taught	in	medical	school,	it’s	a	tradition,	there	may	be	some	partial	
factual	basis	or	database	to	it.	But	a	lot	of	it’s	beliefs.	And	so	you	have	to	realise	it’s	
like	a	religion.	You	can	come	in	with	new	information	and	people	just	don’t	feel	
comfortable	with	it.	They	don’t	have	the	right	gut	feeling,	it	doesn’t	mesh	with	their	
belief	-	obviously	with	ulcers	there	were	about	twenty	other	areas	that	you	would	
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have	which	were	related	to	ulcers.	And	your	whole	understanding	of	
gastroenterology	would	be	based	on	stress.	
Mm.	
And	you’d	manage	all	your	patients	perhaps	quite	successfully	like	that.	So	you	
can’t	just	throw	that	out.	This	is	my	life’s	work,	I’ll	just	chuck	it	out	now,	I’m	just	
the	same	as	a	medical	student	starting	from	scratch.	So	it’s	important	to	be	a	bit	
patient,	because	people	who	start	the	new,	take	on	the	new	technology	or	the	new	
paradigm,	ten	years	from	now	they’re	all	in	the	universities	as	lecturers.	And	they’re	
giving	the	lectures	out	to	the	medical	students.	And	twenty	years	from	now	they’re	
the	head	of	departments.	They’re	the	professors.	So	if	you	say	your	career	starts	in	
specialist	medicine	when	you’re	thirty,	well	then	when	you’re	forty	you’re	the	young	
turk	if	you	like.	And	you’re	running	around	on	the	lecture	circuit,	all	that	exciting	
stuff’s	happening,	and	if	you	put	on	a	good	show,	you’ll	be	then	invited	to	interview	
for	the	new	chief	of	medicine	job.	So	when	you’re	45,	you	are	the	hot	new	chief	of	
medicine	at	the	University	of	Virginia	or	Harvard	or	somewhere.	So	those	years’ll	
go	by	relatively	quickly	once	you	get	in	the	system	and	you’re	quite	busy.	And	then	
it	changes.	And	so	why	did	it	change?	How	come	everybody	suddenly	believes	me?	
Well,	Barry,	because	these	guys	who	are	running	the	medical	schools	are	now	your	
mates.	And	you	are	just	as	old	as	those	professors	used	to	be	when	nobody	believed	
you.	So	they	didn’t	change	their	minds,	they	retired.	
Yes.	
And	now	they’re	out	there,	and	they	probably	still	don’t	really	believe	it!	
Yes.	This	new	fangled	Helicobacter	treatment!	
Yes.	Oh,	yes!	(fogey	professor	voice)	‘So	Dr	Marshall	so	some	ulcers	are	not	caused	
by	stress?	That’s	a	pretty	weird	concept.’	Well,	not	exactly.	Let	me	just	put	it	this	
way.	Hardly	any	ulcers	are	not	caused	by	stress.	Nearly	all	ulcers	are	caused	by	
Helicobacter.	(Makes	fogey-voice	dubious	laugh)	Never.	No	one’ll	ever	believe	that.	
And	so	of	course	I	used	to	get	into	these	big	arguments	in	conferences	and	ram	it	
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down	their	throats.	And	some	people	would	be	not	too	happy.	So	I	could	have	been	
more	diplomatic	on	a	lot	of	occasions!	
(Laughs)		
I	probably	did	myself	made	it	harder	for	myself	at	times.	The	media	lesson	I	learnt,	
if	there’s	no	controversy,	there’s	no	news.	So	now	Helicobacter	is	not	really	news	
because	people	believe	it.	As	soon	as	believed	it,	I	was	sort	of	like,	whoa,	this	is	
pretty	boring,	where	are	we	gonna	go	now?	What	am	I	gonna	do	for	the	rest	of	my	
life?	
Yes.	
So	you	know.	That’s	a	big	problem.	
You’ll	have	to	sit	on	your	laurels.	Or	your	laureates,	depending	.	.	.	
Yes,	so	you	have	to	come	up	with	some	kind	of	new	controversy	so	we’ve	been	--	
Hard	at	work!	
We’ve	been	fanning	the	flames.	
So	what’s	next?	What	new	controversies?	
Well.	You	know,	how	many	years,	how	long	have	humans	had	it?	I	could	do	that…	if	
so	many,	half	the	world’s	infected	with	Helicobacter,	and	they	have	been	infected	
for	a	hundred	thousand	years,	it	must	be	doing	you	some	good.	Otherwise	we	all	
would	have	died	out.	So	what’s	the	answer?	How	does	it	do	you	good?	What	use	is	
it?	And	then,	so	Dr	Blaser	in	the	US	finds	out	that	children	with	Helicobacter	have	
thirty	percent	less	asthma.	
Oh.	
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Oh!	So	it’s	good	to	be	a	little	bit	unclean	and	have	infectious	germs	and	things	on	
you,	cos	otherwise	you	have,	your	immune	system’s	too	hyperactive	and	you’re	
getting	allergies.	Plus	god	only	knows	what	else.	So,	what	are	you	doing	now,	Dr	
Marshall?	Well,	I’m	not	curing	it	anymore,	I’m	giving	it	to	people	to	drink.	So	that	
should	raise	a	bit	of	a	stir.	That’s	true.	
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